Other extrapyramidal and movement disorders in other diseases

G6_XTRAPYROTH

Stiff-Person syndrome: Stiff-man syndrome (SMS) is a rare neurological disorder comprising fluctuating trunk and limb stiffness, painful muscle spasms, task-specific phobia, an exaggerated startle response, and ankylosing deformities such as fixed lumbar hyperlordosis.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G25, G26* Hospital discharge: ICD-9 — 333 Hospital discharge: excluded ICD-9 — 3330\|3336 Cause of death: ICD-10 — G25, G26* Cause of death: ICD-9 — 333 Cause of death: excluded ICD-9 — 3330\|3336 2 out of 7 registries used, show all original rules.	8962
4. Check minimum number of events None	8962
5. Include endpoints G6_RLS	12987
6. Filter based on genotype QC (FinnGen only)	11753

Control definitions (FinnGen only)

Control exclude: G6_XTRAPYR

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF10

NAME	G6_XTRAPYROTH
CONTROL_EXCLUDE	G6_XTRAPYR
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	G6_RLS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G25\|G26
HD_ICD_9	333
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL	3330\|3336
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G25\|G26
COD_ICD_9	333
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL	3330\|3336
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other extrapyramidal and movement disorders in other diseases based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	57572	32364	24873
Only index persons	52038	29908	22130
Unadjusted period prevalence (%)
Whole population	0.82	0.93	0.69
Only index persons	0.99	1.10	0.84
Median age at first event (years)
Whole population	66.04	66.60	65.27
Only index persons	65.34	65.93	64.55

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	11753	7160	4593
Unadjusted period prevalence (%)	2.37	2.54	2.11
Median age at first event (years)	64.51	62.76	67.24

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
12100: Matched controls
121000

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

IAB13

NOMESCO Finland

Psychiatric sleep disorder consultation

49.4

320.0

185

G47.3

ICD-10 Finland

Sleep apnoea

2.2

311.4

3421

18148

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.9

309.5

1640

6180

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

56.5

307.7

1824

379

G25.1

ICD-10 Finland

Drug-induced tremor

198.0

307.7

271

AA5EN

NOMESCO Finland

Brain reseptor or transprot protein distribution isotope imaging

54.1

307.7

249

C07AA05

ATC

propranolol; systemic

4.4

307.7

4505

14399

N04BC09

ATC

rotigotine; transdermal

111.5

307.7

219

N87

ICPC

Parkinsonism

73.9

307.7

584

N02BF01

ATC

gabapentin; oral

4.0

307.7

2535

7461

G25.2

ICD-10 Finland

Other specified forms of tremor

80.3

307.7

654

N06AX21

ATC

duloxetine; oral

2.9

307.7

2111

8348

N03AX12

ATC

[U] gabapentin; oral

3.3

307.7

3237

12057

N04BC04

ATC

ropinirole; oral

90.5

307.7

578

N06AX16

ATC

venlafaxine; oral

2.7

307.7

2285

9733

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

337.4

307.7

1584

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

+∞

307.7

6596

N04BD01

ATC

selegiline; oral

81.9

307.7

442

N06AX11

ATC

mirtazapine; oral

2.5

307.7

5465

29792

N03AX16

ATC

[U] pregabalin

2.4

307.7

3721

18924

G20

ICD-10 Finland

Parkinson disease

286.5

307.7

1327

N04BC05

ATC

pramipexole; oral

23.4

307.7

5097

3652

N04

ICPC

Restless legs

33.1

307.7

493

155

R25.1

ICD-10 Finland

Tremor, unspecified

18.8

307.7

1749

1076

N05AH04

ATC

quetiapine; oral

3.2

307.7

3152

12061

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

+∞

307.7

1110

N05BA04

ATC

oxazepam; oral

2.3

307.7

4087

21786

N03AA03

ATC

primidone; oral

89.7

307.7

246

F51.0

ICD-10 Finland

Nonorganic insomnia

2.6

307.7

2716

12294

G24.3

ICD-10 Finland

Spasmodic torticollis

28.6

307.7

266

N03AE01

ATC

clonazepam; systemic

6.9

307.7

1744

2886

G25.0

ICD-10 Finland

Essential tremor

95.3

307.7

3566

528

R53

ICD-10 Finland

Malaise and fatigue

2.2

306.7

3824

21311

N02BF02

ATC

pregabalin; oral

3.1

290.4

1311

4505

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.6

282.1

1943

8350

N04AA02

ATC

biperiden; systemic

7.2

273.3

415

598

N04BA03

ATC

levodopa, decarboxylase inhibitor and COMT inhibitor; oral

531.5

263.1

261

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.8

259.9

1446

5566

N06AB04

ATC

citalopram; systemic

2.1

258.6

3015

16196

M79.6

ICD-10 Finland

Pain in limb

1.9

258.3

6049

41481

N06AB10

ATC

escitalopram; oral

2.2

256.7

2819

14789

N05CF01

ATC

zopiclone; oral

2.0

252.4

4519

28289

N03AG01

ATC

valproic acid; systemic, rectal

3.3

243.1

1004

3260

M54.5

ICD-10 Finland

Low back pain

1.9

238.3

4969

32548

G25.3

ICD-10 Finland

Myoclonus

272.9

235.3

240

G24.9

ICD-10 Finland

Dystonia, unspecified

78.3

232.1

124

N05AH03

ATC

olanzapine; systemic

3.2

229.9

987

3277

AA1AD

NOMESCO Finland

CT of head and brain

1.9

228.2

4127

25722

N06AX26

ATC

vortioxetine; oral

2.8

208.2

1177

4546

P06

ICPC

Sleep disturbance

2.3

203.6

1902

9261

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.9

203.1

1056

3900

R42

ICD-10 Finland

Dizziness and giddiness

1.9

203.0

3380

20347

N06AX12

ATC

bupropion; oral

2.9

202.7

1035

3785

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.2

201.9

2161

11108

N03AX09

ATC

lamotrigine; oral

3.4

201.8

770

2374

N03AX11

ATC

topiramate; oral

4.7

198.9

472

1035

N06AB06

ATC

sertraline; oral

2.4

196.5

1615

7441

L03

ICPC

Low back symptom/complaint

1.8

192.5

3965

25450

N04BD02

ATC

rasagiline; oral

483.0

191.9

191

N05BA01

ATC

diazepam; systemic, rectal

2.2

185.7

1833

9099

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.8

184.7

1002

3779

N05AN01

ATC

lithium; oral

4.7

183.2

439

970

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.3

180.1

1602

7615

N05AX12

ATC

aripiprazole; systemic

3.7

180.1

598

1682

N05CF02

ATC

zolpidem; oral

2.0

179.5

2375

13145

L17

ICPC

Foot/toe symptom/complaint

1.8

179.4

4198

27856

N02AX02

ATC

tramadol; systemic, rectal

1.7

175.5

5530

39819

R06.0

ICD-10 Finland

Dyspnoea

1.8

173.0

3732

24125

N08

ICPC

Abnormal involuntary movements

18.5

172.1

137

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.2

171.9

711

2300

G04BD12

ATC

mirabegron; oral

2.1

169.7

1836

9421

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.3

169.0

1491

7052

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.4

167.5

1224

5333

G25

ICD-10 Finland

Other extrapyramidal and movement disorders

32.0

167.3

108

IEY18

NOMESCO Finland

Psychiatric sleep coaching, individual

41.6

164.6

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.7

164.0

936

3618

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

163.4

3596

23304

L28

ICPC

Limited function/disability (L)

1.9

162.4

2735

16342

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

4.3

161.5

433

1044

N06AB03

ATC

fluoxetine; oral

2.1

160.6

1682

8511

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.9

160.4

791

2829

M03BX02

ATC

tizanidine; oral

1.7

156.5

7427

58853

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.5

155.8

1102

4723

F02.39*G20

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

768.3

154.7

152

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.4

153.8

1223

5523

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

152.7

5380

39410

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

152.4

4629

32630

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

4.9

150.9

341

717

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.3

149.1

1252

5784

A04

ICPC

Weakness/tiredness general

1.9

148.9

2212

12648

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

5.0

147.7

326

672

193

Kela drug reimbursment

Rasagiline

+∞

146.1

140

M54.4

ICD-10 Finland

Lumbago with sciatica

1.9

144.4

2414

14321

R03AC02

ATC

salbutamol; inhalant

1.6

144.1

6683

52145

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.2

142.7

605

1983

R51.80

ICD-10 Finland

Headache

1.9

142.3

2040

11510

N05AA02

ATC

levomepromazine; systemic

3.2

140.7

592

1931

A02BC02

ATC

pantoprazole; systemic

1.7

140.5

8518

70854

N05BA12

ATC

alprazolam; oral

2.2

140.1

1371

6734

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

140.1

3713

25118

M25.5

ICD-10 Finland

Pain in joint

1.7

139.9

4143

28847

P03

ICPC

Feeling depressed

2.2

138.8

1261

6011

N05CD07

ATC

temazepam; oral

2.1

136.7

1561

8126

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

135.3

3629

24581

N02BE01

ATC

paracetamol; systemic, rectal

2.2

135.2

10957

98649

N06AA09

ATC

amitriptyline; systemic

2.1

134.2

1356

6738

A02BC05

ATC

esomeprazole; systemic

1.6

132.1

5062

37425

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.7

131.3

3419

22944

P76

ICPC

Depressive disorder

2.5

130.7

892

3751

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.1

129.6

1479

7688

P01

ICPC

Feeling anxious/nervous/tense

2.1

127.0

1442

7478

M79.7

ICD-10 Finland

Fibromyalgia

3.0

126.6

573

1949

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

125.0

3725

25810

M48.0

ICD-10 Finland

Spinal stenosis

1.9

124.7

1729

9611

N06AX03

ATC

mianserin; oral

2.7

124.4

712

2747

M79.1

ICD-10 Finland

Myalgia

1.9

123.3

1935

11196

G44.2

ICD-10 Finland

Tension-type headache

1.9

123.1

1787

10083

L01

ICPC

Neck symptom/complaint

1.8

123.0

2140

12782

N06AX22

ATC

agomelatine; oral

3.9

121.8

365

954

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.7

121.1

680

2598

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

3.8

120.9

376

1009

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

3.4

120.6

459

1407

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

119.8

2915

19133

AAG20

NOMESCO Finland

Stereotactic intracranial implantation of electrodes

203.7

116.8

121

R52.9

ICD-10 Finland

Pain, unspecified

2.0

115.4

1440

7709

N06AB05

ATC

paroxetine; oral

2.5

115.4

805

3415

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.5

115.1

781

3271

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.8

114.7

593

2169

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

113.8

5933

46500

G47.9

ICD-10 Finland

Sleep disorder, unspecified

3.2

112.7

468

1513

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

112.5

5263

40248

A01

ICPC

Pain general/multiple sites

2.0

112.2

1419

7627

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

111.9

2442

15525

N06AX05

ATC

trazodone; oral

3.5

109.3

394

1167

P29

ICPC

Psychological sympt/compl other

2.3

108.3

909

4178

F31.8

ICD-10 Finland

Other bipolar affective disorders

4.2

106.7

286

689

SPAT1240

SPAT

Therapeutic discussion

2.0

106.4

1204

6216

N05AX08

ATC

risperidone; systemic

2.1

103.6

1086

5447

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

5.0

103.5

224

454

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.0

103.4

1323

7128

G24.8

ICD-10 Finland

Other dystonia

137.5

102.2

109

R02

ICPC

Shortness of breath/dyspnoea

1.8

102.1

1832

10986

F32

ICD-10 Finland

Depressive episode

2.5

101.7

697

2929

R06.5

ICD-10 Finland

Mouth breathing

2.1

101.7

1118

5707

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

101.0

2360

15228

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

176.5

100.4

105

A02BC03

ATC

lansoprazole; oral

1.6

100.3

3453

24497

M70.6

ICD-10 Finland

Trochanteric bursitis

1.8

99.8

1806

10851

A28

ICPC

Limited function/disability NOS

1.7

99.6

2368

15344

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

99.4

2582

17115

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

4.7

98.9

230

495

F34.1

ICD-10 Finland

Dysthymia

2.8

98.6

501

1814

P20

ICPC

Memory disturbance

1.8

98.5

1909

11696

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

98.0

8298

71035

F32.1

ICD-10 Finland

Moderate depressive episode

2.4

97.5

717

3110

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.8

96.9

1772

10671

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

96.8

1606

9396

R25.8

ICD-10 Finland

Other and unspecified abnormal involuntary movements

10.7

96.7

105

N17

ICPC

Vertigo/dizziness

1.8

95.3

1729

10384

S18

ICPC

Laceration/cut

1.5

94.1

5735

45735

R01AD09

ATC

mometasone; nasal

1.5

94.1

5187

40546

XA800

NOMESCO Finland

Neuropsychological investigation

2.6

94.0

549

2136

R20.2

ICD-10 Finland

Paraesthesia of skin

2.1

93.8

951

4704

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

3.4

93.8

353

1074

M01AH05

ATC

etoricoxib; oral

1.5

93.5

7237

60490

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

92.8

2231

14467

N29

ICPC

Neurological sympt/complt other

3.5

92.7

319

916

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.0

92.5

1064

5513

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

92.0

3124

22010

N05AF03

ATC

chlorprothixene; systemic

3.3

91.8

354

1093

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

3.5

91.3

315

906

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

4.4

90.8

227

518

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.0

90.3

1076

5644

G23.9

ICD-10 Finland

Degenerative disease of basal ganglia, unspecified

885.2

89.9

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.6

89.8

531

2078

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.8

89.7

1549

9156

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

89.6

2736

18791

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

88.8

5263

41574

TAB00

NOMESCO Finland

Lumbar puncture

2.5

88.4

590

2447

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

88.2

3807

28205

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

87.6

1374

7885

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

87.4

3592

26330

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

3.7

87.0

275

746

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.5

86.8

3085

21909

IGY02

NOMESCO Finland

Psychiatric monitoring contact

3.0

86.5

398

1364

R4110, ,

SPAT

1.7

86.4

1751

10826

R03DC03

ATC

montelukast; oral

1.7

85.5

1958

12507

R13

ICD-10 Finland

Dysphagia

2.0

85.2

943

4813

A02BC01

ATC

omeprazole; systemic

1.5

85.2

3234

23284

G21.9

ICD-10 Finland

Secondary parkinsonism, unspecified

151.1

85.1

K59.09

ICD-10 Finland

Constipation, unspecified

2.0

85.0

943

4818

Z71.8

ICD-10 Finland

Other specified counselling

1.5

84.8

4004

30157

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

3.1

84.7

366

1210

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

3.6

84.4

279

780

L12

ICPC

Hand/finger symptom/complaint

1.6

84.4

2109

13771

R25.2

ICD-10 Finland

Cramp and spasm

3.0

82.5

376

1282

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.1

82.1

841

4170

R35

ICD-10 Finland

Polyuria

2.0

81.9

900

4581

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.2

81.3

323

1016

P99

ICPC

Psychological disorders other

2.9

80.7

392

1384

R60.0

ICD-10 Finland

Localized oedema

1.7

80.3

1651

10232

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.9

80.0

382

1336

A06AD11

ATC

lactulose; oral

1.7

79.9

1775

11231

SPAT1216

SPAT

Assessment of functional ability

1.7

79.9

1925

12439

N30.0

ICD-10 Finland

Acute cystitis

1.6

79.8

2159

14357

N05BA06

ATC

lorazepam; systemic, sublingual

2.3

79.2

655

2983

N05BE01

ATC

buspirone; oral

2.8

79.1

397

1427

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

79.0

7540

64524

C07AB07

ATC

bisoprolol; oral

1.4

78.7

5801

47344

K02.1

ICD-10 Finland

Caries of dentine

1.4

78.7

6590

55041

J01DB01

ATC

cefalexin; oral

1.6

78.4

9721

87571

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

2.7

78.3

420

1564

L02

ICPC

Back symptom/complaint

1.8

78.1

1256

7249

G47.2

ICD-10 Finland

Disorders of the sleep-wake schedule

9.7

77.7

Z01.2

ICD-10 Finland

Dental examination

1.4

77.1

5282

42477

M01AB05

ATC

diclofenac; systemic, rectal

1.4

77.1

7551

64773

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

76.9

8235

71811

M01AE02

ATC

naproxen; oral, rectal

1.4

76.6

6349

52813

N06AG02

ATC

moclobemide; oral

2.4

76.6

563

2437

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

76.5

1976

12979

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

76.3

4743

37452

SPAT1301

SPAT

No procedures

1.5

76.3

3660

27519

N06AA06

ATC

trimipramine; systemic

3.0

76.0

344

1168

E0000UV, ,

ATC

1.4

76.0

4842

38399

ZY010

NOMESCO Finland

Hospital outpatient

2.3

75.8

604

2708

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.8

75.8

402

1488

H02AB06

ATC

prednisolone; systemic

1.4

75.4

5590

45531

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

75.1

1641

10324

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

75.1

5383

43575

J01AA02

ATC

doxycycline; systemic

1.5

75.0

9079

80837

F31

ICD-10 Finland

Bipolar affective disorder

4.3

74.9

192

447

R52.2

ICD-10 Finland

Other chronic pain

2.4

74.8

526

2232

J45

ICD-10 Finland

Asthma

1.8

74.7

1278

7509

G47.0

ICD-10 Finland

Disorders of initiating and maintaining sleep [insomnias]

2.9

74.4

352

1225

N04BX02

ATC

entacapone; oral

+∞

74.0

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.5

73.4

474

1934

J02AC01

ATC

fluconazole; systemic

1.4

73.3

4415

34589

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

5.0

73.0

156

313

G23.1

ICD-10 Finland

Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]

+∞

71.9

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

71.8

2064

13887

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

71.6

1248

7368

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

71.3

1235

7278

L13

ICPC

Hip symptom/complaint

1.5

71.2

2422

16922

D01

ICPC

Abdominal pain/cramps general

1.7

71.0

1473

9130

M03BX01

ATC

baclofen; systemic

3.3

70.8

273

843

U07

ICPC

Urine symptom/complaint other

1.8

70.7

1113

6374

N06AA12

ATC

doxepin; systemic

2.2

70.3

657

3141

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.2

70.3

287

918

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

69.8

1943

12963

AEA50

NOMESCO Finland

Adjustment of implanted neurostimulator

9.7

69.8

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.8

69.2

363

1335

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

69.0

1820

11985

SFA10

NOMESCO Finland

One-surface restoration

1.4

69.0

6165

51552

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

4.0

68.7

194

486

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.7

68.6

1375

8437

R05

ICD-10 Finland

Cough

1.5

68.6

2548

18120

3AX01, ,

NOMESCO Finland

12.2

68.4

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

7.0

68.4

104

150

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.3

68.0

256

779

SPAT1053

SPAT

Memory test

1.6

67.9

1739

11365

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.7

67.8

214

580

G43.9

ICD-10 Finland

Migraine, unspecified

2.1

67.7

672

3288

UJF32

NOMESCO Finland

Coloscopy

1.5

67.0

3113

23142

N05AB03

ATC

perphenazine; systemic, rectal

2.5

66.9

419

1685

ZYC01

NOMESCO Finland

Remote contact by phone

2.0

66.7

757

3891

R55

ICD-10 Finland

Syncope and collapse

1.7

66.6

1352

8322

U02

ICPC

Urinary frequency/urgency

1.6

66.6

1842

12259

P74

ICPC

Anxiety disorder/anxiety state

2.3

66.5

514

2273

SPAT1260

SPAT

Consultation of another employee

1.6

66.5

2045

13947

F51

ICD-10 Finland

Nonorganic sleep disorders

2.3

66.2

515

2284

A97

ICPC

No disease

1.5

65.9

2375

16763

SPAT1254

SPAT

Administration of medicine

1.6

65.9

1733

11394

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

65.8

2240

15620

SPAT1229

SPAT

Assessment of need for aid

1.9

65.7

945

5257

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

3.5

65.5

227

655

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.6

65.5

376

1449

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

65.5

4124

32389

IHZ05, ,

SPAT

2.4

65.4

461

1958

Z2445

NOMESCO Finland

Psychologist

2.5

65.2

432

1783

AA400

NOMESCO Finland

Electroconvulsive therapy

5.3

65.1

132

253

H03AA01

ATC

levothyroxine sodium; systemic

1.5

64.8

2711

19722

SFA20

NOMESCO Finland

Two-surface restoration

1.4

64.7

6469

54858

L08

ICPC

Shoulder symptom/complaint

1.5

64.6

2723

19836

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

64.2

6166

51918

M54

ICD-10 Finland

Dorsalgia

1.7

64.2

1411

8865

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.8

64.1

328

1191

SPAT1263

SPAT

Sampling

1.4

64.1

4718

38018

IGY99

NOMESCO Finland

Other psychiatric treatment contact

3.3

63.8

249

775

L15

ICPC

Knee symptom/complaint

1.5

63.7

2976

22107

3338X

ICD-9 Finland

Other extrapyramidal disease and abnormal movement disorders, Fragments of torsion dystonia

+∞

63.6

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.0

63.5

678

3408

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.7

63.3

1347

8390

R5110, ,

SPAT

1.8

63.0

1126

6686

R07.3

ICD-10 Finland

Other chest pain

1.7

62.3

1251

7669

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

62.1

1435

9126

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

62.1

3367

25692

XKD00

NOMESCO Finland

Uroflowmetry

1.6

62.0

1718

11420

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

62.0

1518

9797

I95.1

ICD-10 Finland

Orthostatic hypotension

2.2

61.8

518

2370

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

61.8

2115

14743

J01CA04

ATC

amoxicillin; systemic

1.5

61.6

9371

84972

R06AE07

ATC

cetirizine; oral

1.4

61.6

4892

39836

R03BA08

ATC

ciclesonide; inhalant

1.8

61.5

1028

5983

K30

ICD-10 Finland

Functional dyspepsia

1.7

61.5

1354

8504

N04BX04

ATC

opicapone; oral

+∞

61.5

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.5

61.5

403

1655

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

61.4

2198

15465

K59.0

ICD-10 Finland

Constipation

2.0

61.0

719

3742

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

3.1

60.8

255

829

R01AD58

ATC

fluticasone, combinations; nasal

1.5

60.6

2644

19356

R11

ICD-10 Finland

Nausea and vomiting

1.8

60.2

1053

6210

S29

ICPC

Skin symptom/complaint other

1.5

60.1

2434

17552

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.1

60.1

616

3048

N01

ICPC

Headache

1.7

59.8

1207

7405

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

59.7

5068

41643

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.8

59.7

1031

6058

N06DA03

ATC

rivastigmine; oral, transdermal

2.2

59.4

545

2585

S06.0

ICD-10 Finland

Concussion

1.7

59.3

1227

7578

F61.0

ICD-10 Finland

Mixed personality disorders

3.4

59.1

217

650

UKC02

NOMESCO Finland

Cystoscopy

1.6

59.1

1820

12385

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

59.0

1199

7371

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.9

58.9

743

3958

K59.1

ICD-10 Finland

Functional diarrhoea

2.0

58.3

714

3764

F90.0

ICD-10 Finland

Disturbance of activity and attention

2.6

58.1

353

1398

M01AC06

ATC

meloxicam; systemic, rectal

1.4

58.1

4043

32124

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

57.9

2665

19684

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

57.3

4319

34749

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.6

56.9

332

1289

R01AD08

ATC

fluticasone; nasal

1.4

56.8

3081

23435

G31.8

ICD-10 Finland

Other specified degenerative diseases of nervous system

5.8

56.8

103

178

J01EA01

ATC

trimethoprim; systemic

1.4

56.7

2942

22200

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

56.6

1495

9810

E61.1

ICD-10 Finland

Iron deficiency

2.7

56.6

306

1144

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.5

56.4

373

1538

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

56.0

4673

38168

N99

ICPC

Neurological disease other

3.5

55.9

197

575

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

55.9

5753

48538

R60.9

ICD-10 Finland

Oedema, unspecified

1.9

55.8

730

3934

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

3.7

55.6

179

492

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

55.6

1574

10497

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.4

55.6

374

1555

R03BB04

ATC

tiotropium bromide; inhalant

1.7

55.5

1156

7147

A29

ICPC

General symptom/complaint other

1.6

55.3

1619

10878

R06AX27

ATC

desloratadine; oral

1.4

55.1

3026

23049

R49.02

ICD-10 Finland

Spasmodic dysphonia

10.6

55.0

R05

ICPC

Cough

1.4

55.0

2871

21671

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

5.5

54.7

106

195

R03BA02

ATC

budesonide; inhalant

1.5

54.6

1979

13924

N06BA04

ATC

methylphenidate; oral

2.6

54.6

321

1252

Z01.7

ICD-10 Finland

Laboratory examination

1.5

54.5

1922

13442

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

54.4

1564

10461

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

54.4

2900

21964

A98

ICPC

Health maint/preventive medicine

2.0

54.2

11522

110177

F45.8

ICD-10 Finland

Other somatoform disorders

1.9

54.1

712

3844

M54.2

ICD-10 Finland

Cervicalgia

1.8

54.0

922

5392

SPAT1307

SPAT

Psychosocial counselling and guidance

2.0

53.9

571

2860

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.9

53.9

740

4051

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

53.7

3166

24391

R00.2

ICD-10 Finland

Palpitations

1.8

53.7

934

5492

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.7

53.5

1044

6339

WX290

NOMESCO Finland

Other blockage of nerve

1.3

53.1

4927

40804

J31.0

ICD-10 Finland

Chronic rhinitis

1.7

52.9

966

5758

R25.0

ICD-10 Finland

Abnormal head movements

19.6

52.8

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.4

52.4

372

1584

N28

ICPC

Limited function/disability (N)

2.9

52.2

244

844

D11

ICPC

Diarrhoea

1.6

52.1

1313

8509

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

52.1

3271

25443

P01AB01

ATC

metronidazole; oral, rectal

1.4

52.1

4406

35942

A11

ICPC

Chest pain NOS

1.7

52.1

1053

6453

IBA03

NOMESCO Finland

Psychotherapy evaluation

4.5

52.0

128

289

A02BA02

ATC

ranitidine; systemic

1.5

51.9

2118

15245

SPAT1310

SPAT

Counselling related to known health issue

1.4

51.8

3472

27296

L14

ICPC

Leg/thigh symptom/complaint

1.7

51.6

987

5958

R96

ICPC

Asthma

1.6

51.6

1184

7498

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.8

51.2

269

991

SPAT1153

SPAT

Removal of sutures

1.4

51.2

3529

27862

A02BC04

ATC

rabeprazole; oral

1.7

51.1

990

5997

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.0

50.9

579

2973

M54.1

ICD-10 Finland

Radiculopathy

2.1

50.8

488

2356

Z3226

NOMESCO Finland

Physiotherapist

1.5

50.4

1976

14098

N05AH02

ATC

clozapine; systemic

3.3

50.4

191

584

R12

ICD-10 Finland

Heartburn

1.7

50.2

984

5979

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

4.2

49.7

131

312

D06

ICPC

Abdominal pain localized other

1.7

49.7

1052

6523

A08

ICPC

Swelling

1.8

49.7

730

4080

D07AC01

ATC

betamethasone; topical

1.4

49.7

4045

32742

R03BA05

ATC

fluticasone; inhalant

1.5

49.5

1947

13896

N04BB01

ATC

amantadine; oral

3.2

49.2

194

608

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

49.1

2350

17405

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

48.8

2506

18799

H81

ICPC

Excessive ear wax

1.5

48.7

2031

14657

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.2

48.6

402

1828

H53.1

ICD-10 Finland

Subjective visual disturbances

1.8

48.5

839

4921

D82

ICPC

Teeth/gum disease

1.4

48.5

3951

31952

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.1

48.5

453

2163

L86

ICPC

Back syndrome with radiating pain

1.8

48.4

750

4259

D12

ICPC

Constipation

2.1

48.3

480

2346

SPAT1234

SPAT

Support of social functional capacity

1.9

48.3

620

3317

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

48.1

940

5706

Z02.7

ICD-10 Finland

Issue of medical certificate

1.7

48.0

863

5118

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.8

47.9

733

4146

G25.5

ICD-10 Finland

Other chorea

+∞

47.9

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.1

47.9

459

2213

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.5

47.8

2080

15127

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

4.4

47.7

120

276

R27.0

ICD-10 Finland

Ataxia, unspecified

5.7

47.6

155

L16

ICPC

Ankle symptom/complaint

1.6

47.5

1351

8998

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.6

47.4

1332

8845

R01AD12

ATC

fluticasone furoate; nasal

1.4

47.4

3234

25422

C03CA01

ATC

furosemide; systemic

1.4

47.3

3455

27449

J45.1

ICD-10 Finland

Nonallergic asthma

1.8

47.0

818

4807

A99

ICPC

Disease/condition unspecnature/site

1.6

46.8

1214

7911

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

46.6

4126

33733

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

5.3

46.6

176

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.1

46.6

470

2311

R51

ICD-10 Finland

Headache

1.9

46.5

617

3338

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

3.1

46.4

197

645

L29

ICPC

Musculoskeletal sympt/complt other

1.6

46.2

1059

6697

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.5

46.1

159

458

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.6

45.9

1225

8035

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

4.0

45.8

128

319

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

45.5

2518

19102

SPAT1312

SPAT

General health counselling

1.4

45.3

3377

26880

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.2

45.2

373

1694

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

45.0

2748

21187

N03AF01

ATC

carbamazepine; oral, rectal

1.9

44.9

548

2882

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

44.8

4529

37678

3331A

ICD-9 Finland

Other extrapyramidal disease and abnormal movement disorders, Essential and other specified forms of tremor

+∞

44.8

N05AE05

ATC

lurasidone; oral

6.9

44.8

101

R03BA01

ATC

beclometasone; inhalant

1.5

44.8

1522

10528

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

44.7

1088

6980

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

5.0

44.7

194

SPAT1243

SPAT

Psychiatric/psychological examination

2.6

44.6

260

1010

G04BD08

ATC

solifenacin; oral

1.8

44.6

771

4521

SFA30

NOMESCO Finland

Three-surface restoration

1.3

44.2

4563

38056

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

44.1

1517

10515

R74

ICPC

Upper respiratory infection acute

1.4

43.8

3315

26421

F40.1

ICD-10 Finland

Social phobias

2.7

43.7

246

939

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

43.7

1522

10578

M01AH01

ATC

celecoxib; oral

1.4

43.7

1968

14381

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.9

43.5

541

2864

N07BB01

ATC

disulfiram; oral

2.1

43.5

421

2038

G04CA02

ATC

tamsulosin; oral

1.4

43.4

2350

17742

Z3231

NOMESCO Finland

Registered nurse

1.4

43.2

2923

22887

M01AG02

ATC

tolfenamic acid; oral, rectal

1.5

43.1

1528

10655

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

42.8

3936

32256

M54.6

ICD-10 Finland

Pain in thoracic spine

1.7

42.8

810

4870

J01MA02

ATC

ciprofloxacin; systemic

1.3

42.4

4278

35500

Z00.0

ICD-10 Finland

General medical examination

1.4

42.4

2099

15595

U05

ICPC

Urination problems other

1.8

42.1

635

3574

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

42.1

2234

16797

R50.9

ICD-10 Finland

Fever, unspecified

1.5

42.0

1621

11492

N05AD01

ATC

haloperidol; systemic

2.2

41.7

340

1538

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.9

41.5

535

2865

M02AA07

ATC

piroxicam; topical

1.3

41.5

3898

32003

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.5

41.5

1475

10287

R03AK08

ATC

formoterol and beclometasone; inhalant

1.9

41.3

515

2728

R03AC03

ATC

terbutaline; inhalant

1.5

41.3

1468

10238

N30.9

ICD-10 Finland

Cystitis, unspecified

1.7

41.2

769

4603

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.4

41.0

287

1215

K07

ICPC

Swollen ankles/oedema

1.8

40.9

596

3319

R21

ICPC

Throat symptom/complaint

1.4

40.8

2079

15508

J01FA06

ATC

roxithromycin; oral

1.3

40.8

4230

35186

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

3.6

40.7

134

375

R4110

NOMESCO Finland

Physiotherapy

1.3

40.6

3032

24058

D09

ICPC

Nausea

1.9

40.5

504

2667

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

40.4

1441

10052

G04CA01

ATC

alfuzosin; oral

1.5

40.3

1216

8187

J01CA08

ATC

pivmecillinam; oral

1.3

40.3

4429

37112

U04

ICPC

Incontinence urine

1.7

40.3

706

4153

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

39.9

2345

17911

F33

ICD-10 Finland

Recurrent depressive disorder

2.5

39.5

247

993

F41.8

ICD-10 Finland

Other specified anxiety disorders

2.3

39.1

315

1417

R32

ICD-10 Finland

Unspecified urinary incontinence

2.2

39.1

352

1657

J01FA10

ATC

azithromycin; systemic

1.3

39.1

6057

52996

C10AA05

ATC

atorvastatin; oral

1.3

39.1

4762

40402

DQD34

NOMESCO Finland

Treatment of spasmodic dysfonia

13.9

39.0

N05AA01

ATC

chlorpromazine; systemic, rectal

3.3

39.0

150

464

M54.3

ICD-10 Finland

Sciatica

1.7

38.9

671

3929

J01DA01

ATC

[U] cefalexin

1.3

38.8

6702

59428

G21.8

ICD-10 Finland

Other secondary parkinsonism

105.4

38.7

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.7

38.7

774

4721

XF402

NOMESCO Finland

ECG with work load test

1.5

38.3

1141

7660

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

38.2

2815

22254

WX723

NOMESCO Finland

CPAP therapy

1.9

38.2

478

2536

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.6

38.0

882

5586

A06AC51

ATC

ispaghula, combinations; oral

1.8

38.0

548

3043

IGY02, ,

SPAT

2.9

37.9

179

624

Z2446

NOMESCO Finland

Social worker

1.8

37.8

647

3778

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.1

37.8

378

1852

K07.60

ICD-10 Finland

Snapping jaw

1.9

37.8

524

2874

M03AX01

ATC

botulinum toxin; parenteral

3.1

37.7

155

499

S21

ICPC

Skin texture symptom/complaint

1.4

37.6

1712

12501

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.1

37.6

343

1623

L29.9

ICD-10 Finland

Pruritus, unspecified

2.2

37.5

337

1585

3339X

ICD-9 Finland

Other extrapyramidal disease and abnormal movement disorders, Other and unspecified extrapyramidal diseases and abnormal movement disorders

+∞

37.5

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.8

37.4

544

3027

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

37.4

1573

11320

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

4.9

37.4

165

SDA03

NOMESCO Finland

Periodontal treatment

1.3

37.3

4300

36152

G47.8

ICD-10 Finland

Other sleep disorders

2.8

37.2

192

702

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.1

36.9

353

1701

R1250

NOMESCO Finland

Evaluation of functional capability

2.3

36.8

291

1300

N03AF02

ATC

oxcarbazepine; oral

2.1

36.8

349

1677

M02AA10

ATC

ketoprofen; topical

1.4

36.8

1728

12687

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

4.6

36.7

187

N40

ICD-10 Finland

Hyperplasia of prostate

1.4

36.7

2120

16122

WX002

NOMESCO Finland

Sedation and analgesia

1.4

36.6

2072

15702

EBA00

NOMESCO Finland

Extraction of tooth

1.3

36.6

3813

31614

R4120

NOMESCO Finland

Occupational therapy

1.7

36.6

709

4286

Z71.9

ICD-10 Finland

Counselling, unspecified

1.6

36.4

880

5627

A05

ICPC

Feeling ill

1.8

36.3

594

3425

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.9

36.2

454

2409

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

36.2

1979

14909

N04BC06

ATC

cabergoline; oral

5.1

36.1

151

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.9

35.9

455

2423

J20

ICD-10 Finland

Acute bronchitis

1.5

35.9

1112

7523

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.5

35.7

1086

7318

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

35.7

3781

31393

D19

ICPC

Teeth/gum symptom/complaint

1.3

35.6

3204

26021

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.7

35.6

636

3759

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.7

35.5

641

3800

OAB93, ,

SPAT

1.8

35.4

603

3517

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

35.4

1709

12602

N06AB08

ATC

fluvoxamine; oral

2.2

35.4

292

1328

N06AX17

ATC

milnacipran; oral

3.2

35.3

140

441

G93.3

ICD-10 Finland

Postviral fatigue syndrome

5.1

35.2

143

SPAT1058

SPAT

PEF monitoring instruction

1.6

35.2

876

5640

S01GX01

ATC

cromoglicic acid; ophthalmic

1.4

35.1

2026

15390

G24.5

ICD-10 Finland

Blepharospasm

58.8

35.1

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

35.1

882

5691

S04

ICPC

Lump/swelling localized

1.5

35.1

1193

8228

WX780

NOMESCO Finland

Remote monitoring CPAP

1.9

34.9

477

2603

C05AA08

ATC

fluocortolone; rectal, topical

1.5

34.9

1415

10103

A03

ICPC

Fever

1.4

34.8

1700

12556

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

34.8

1363

9670

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

34.7

1614

11816

G23.8

ICD-10 Finland

Other specified degenerative diseases of basal ganglia

95.3

34.7

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

34.7

2096

16038

M01AX17

ATC

nimesulide; oral

1.3

34.7

2533

19956

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.5

34.7

1179

8131

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

34.6

2669

21196

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

34.6

4035

33889

Z2221

NOMESCO Finland

Medical doctor

1.3

34.5

2828

22654

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.8

34.5

493

2729

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

4.2

34.3

214

H13

ICPC

Plugged feeling ear

1.4

34.3

2166

16687

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.3

34.3

2389

18684

G62.8

ICD-10 Finland

Other specified polyneuropathies

3.3

34.3

127

384

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.9

34.2

481

2648

EB1VA, ,

NOMESCO Finland

1.4

34.1

1870

14082

H02

ICPC

Hearing complaint

1.4

34.1

1684

12459

J46

ICD-10 Finland

Status asthmaticus

2.1

34.0

332

1613

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.6

33.9

770

4846

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.8

33.9

536

3060

L60.0

ICD-10 Finland

Ingrowing nail

1.8

33.9

519

2935

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.8

33.8

556

3209

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

33.8

1920

14538

P25

ICPC

Phase of life problem adult

1.9

33.7

422

2238

F39

ICD-10 Finland

Unspecified mood [affective] disorder

2.7

33.4

181

679

E66.01

ICD-10 Finland

Obesity due to excess calories

1.6

33.4

930

6144

KMAK, ,

NOMESCO Finland

1.3

33.3

5254

45710

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.9

33.3

442

2389

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.7

33.3

615

3668

N39.3

ICD-10 Finland

Stress incontinence

1.6

33.3

818

5249

H01

ICPC

Ear pain/earache

1.5

33.2

1205

8418

R06AX22

ATC

ebastine; oral

1.4

33.2

1725

12870

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.8

33.1

488

2728

H02AA02

ATC

fludrocortisone; oral

3.7

33.0

103

278

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.3

33.0

3090

25180

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

33.0

3305

27178

N06AA10

ATC

nortriptyline; systemic

2.4

32.8

230

975

R44.1

ICD-10 Finland

Visual hallucinations

4.4

32.6

181

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

3.5

32.6

112

323

N30

ICD-10 Finland

Cystitis

1.6

32.5

877

5752

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.4

32.4

1436

10414

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.6

32.3

756

4793

WZC00, ,

SPAT

1.4

32.3

1592

11765

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

32.2

4816

41588

A03FA02

ATC

cisapride; oral, rectal

1.6

32.1

781

4997

SCA01

NOMESCO Finland

Preventive oral health care, short

1.3

32.1

2814

22713

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

32.1

2820

22771

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.4

32.1

113

331

H02AB07

ATC

prednisone; oral

1.4

32.0

1407

10189

N06BA07

ATC

modafinil; oral

5.7

32.0

104

SPAT1325

SPAT

Vaccination

1.3

31.9

3592

29954

L05

ICPC

Flank/axilla symptom/complaint

1.6

31.8

704

4403

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

4.2

31.8

197

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.3

31.8

243

1071

U01

ICPC

Dysuria/painful urination

1.6

31.7

867

5702

L19

ICPC

Muscle symptom/complaint NOS

2.0

31.6

336

1684

G47.1

ICD-10 Finland

Disorders of excessive somnolence [hypersomnias]

6.3

31.6

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.4

31.4

210

872

G04BD07

ATC

tolterodine; oral

1.8

31.3

518

2996

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.2

31.3

274

1277

XG466

NOMESCO Finland

Sleep oxymetry

2.0

31.3

323

1603

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

31.1

1124

7841

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

31.1

3073

25189

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.0

31.0

347

1771

Z01.9

ICD-10 Finland

Special examination, unspecified

1.7

31.0

652

4024

R33

ICD-10 Finland

Retention of urine

1.6

30.9

809

5265

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

30.8

784

5069

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.4

30.8

213

898

A03CA02

ATC

clidinium and psycholeptics; oral

1.7

30.8

608

3693

S02

ICPC

Pruritus

1.9

30.6

393

2102

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.3

30.6

2972

24293

W19

ICD-10 Finland

Unspecified fall

1.5

30.6

1033

7108

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.0

30.5

313

1549

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

2.7

30.5

161

596

H29

ICPC

Ear symptom/complaint other

1.4

30.5

1341

9707

N76.0

ICD-10 Finland

Acute vaginitis

1.7

30.3

572

3433

D21

ICPC

Swallowing problem

2.5

30.3

185

737

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

2.8

30.2

151

543

N02AA05

ATC

oxycodone; systemic

1.3

30.0

1990

15411

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.4

29.8

1277

9195

IHZ04, ,

SPAT

2.6

29.8

174

678

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

4.5

29.8

157

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.4

29.7

1413

10365

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

29.7

805

5282

N89

ICPC

Migraine

2.0

29.7

320

1613

M01AH02

ATC

rofecoxib; oral

1.4

29.6

1323

9602

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

3.1

29.6

126

415

A07AA02

ATC

nystatin; oral

1.6

29.5

630

3904

S22.3

ICD-10 Finland

Fracture of rib

1.6

29.5

734

4722

F51.5

ICD-10 Finland

Nightmares

9.7

29.4

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.3

29.4

3686

31076

A01AB09

ATC

miconazole; local oral

1.5

29.4

893

6008

WX408

NOMESCO Finland

General anesthesy, balanced

1.3

29.3

2650

21441

IBZ07

NOMESCO Finland

Neurological assessment in psychiatry

6.7

29.2

R06AE09

ATC

levocetirizine; oral

1.4

29.2

1379

10103

G43.3

ICD-10 Finland

Complicated migraine

2.5

29.2

176

697

U71

ICPC

Cystitis/urinary infection other

1.6

29.1

761

4950

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

29.1

6977

63226

R30.1

ICD-10 Finland

Vesical tenesmus

2.2

29.1

258

1208

F41.3

ICD-10 Finland

Other mixed anxiety disorders

2.7

29.1

152

560

K08.80

ICD-10 Finland

Toothache NOS

1.5

29.1

883

5940

S22

ICPC

Nail symptom/complaint

1.6

29.0

729

4699

C10AA07

ATC

rosuvastatin; oral

1.3

29.0

3655

30821

G04BD04

ATC

oxybutynin; oral, transdermal

1.7

28.9

545

3269

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.4

28.9

196

820

G25.6

ICD-10 Finland

Drug-induced tics and other tics of organic origin

292.7

28.8

SPAT1360

SPAT

Extensive global examination

1.6

28.8

724

4669

F33.8

ICD-10 Finland

Other recurrent depressive disorders

3.3

28.7

108

330

G43

ICD-10 Finland

Migraine

1.8

28.7

458

2621

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

2.3

28.7

228

1022

IBA01, ,

SPAT

2.4

28.7

197

829

R01AD01

ATC

beclometasone; nasal

1.4

28.6

1505

11227

N06AA04

ATC

clomipramine; systemic

2.5

28.6

185

757

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

28.6

3934

33503

N05AF01

ATC

flupentixol; systemic

2.5

28.6

173

686

N05AE04

ATC

ziprasidone; systemic

4.2

28.5

179

SPAT1097

SPAT

Recording of ECG

1.4

28.5

1526

11417

E66.8

ICD-10 Finland

Other obesity

1.7

28.5

538

3229

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.5

28.3

878

5933

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.5

28.2

181

738

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.7

28.2

508

3009

XQ800

NOMESCO Finland

Prick test

1.6

28.2

686

4390

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

28.1

1932

15027

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.3

28.1

2320

18522

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.0

28.1

309

1569

SPAT1211

SPAT

Application of soft bandage

1.5

28.1

893

6065

M43.1

ICD-10 Finland

Spondylolisthesis

1.8

28.1

429

2424

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.5

28.1

830

5551

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

28.0

10158

96450

P73

ICPC

Affective psychosis

4.8

28.0

129

JN3AD

NOMESCO Finland

Abdominal CT examination

1.4

28.0

1417

10504

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

28.0

1007

7014

R47.1

ICD-10 Finland

Dysarthria and anarthria

3.1

27.9

117

382

F29

ICPC

Eye symptom/complaint other

1.4

27.8

1117

7945

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.6

27.8

767

5052

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.5

27.7

846

5697

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

4.0

27.7

192

N05AL01

ATC

sulpiride; systemic

2.6

27.6

163

639

ZX114

NOMESCO Finland

Intramuscular

2.7

27.6

151

570

SBB10

NOMESCO Finland

Dental impressions

1.6

27.6

610

3813

R4130

NOMESCO Finland

Speech therapy

2.1

27.5

274

1342

L04

ICPC

Chest symptom/complaint

1.6

27.5

685

4406

SPAT1043

SPAT

Audiometry

1.5

27.4

1080

7651

R4120, ,

SPAT

2.5

27.4

171

688

H53.2

ICD-10 Finland

Diplopia

1.9

27.4

347

1848

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

27.4

1179

8493

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

1.9

27.3

370

2014

ZXA10

NOMESCO Finland

Bilateral

1.3

27.3

1925

15024

WYA10

NOMESCO Finland

Emergency care or similar visit

1.6

27.1

707

4597

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

27.0

1255

9161

L84

ICPC

Back syndrome without radiat pain

1.7

27.0

511

3068

F41.00

ICD-10 Finland

Moderate panic disorder

2.6

27.0

158

617

G04BD09

ATC

trospium; oral

2.0

26.9

277

1373

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.6

26.9

607

3812

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

26.9

849

5755

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.5

26.9

912

6275

N05AC02

ATC

thioridazine; oral

2.4

26.9

188

798

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.7

26.8

500

2989

R49.03

ICD-10 Finland

Atrophic dysphonia

2.6

26.7

152

585

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.9

26.7

363

1979

K10.3

ICD-10 Finland

Alveolitis of jaws

1.7

26.7

456

2662

C07AA07

ATC

sotalol; systemic

1.8

26.7

374

2059

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

26.5

1829

14224

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

26.5

1003

7053

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.7

26.4

532

3246

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.7

26.4

501

3009

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

26.4

2773

22817

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

26.4

1365

10149

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

26.3

819

5536

A01AB04

ATC

amphotericin B; local oral

1.7

26.3

477

2831

H02AB04

ATC

methylprednisolone; systemic

1.4

26.3

1466

11033

M54.8

ICD-10 Finland

Other dorsalgia

1.7

26.2

480

2856

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.8

26.2

434

2511

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.9

26.2

354

1926

XKC03

NOMESCO Finland

Water cystometry

1.9

26.2

325

1721

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

26.1

7143

65268

P72

ICPC

Schizophrenia

2.4

26.0

174

724

N05AX15

ATC

cariprazine; oral

5.2

25.9

103

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.1

25.9

260

1278

R49.08

ICD-10 Finland

Other specified dysphonia

2.1

25.9

246

1185

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

25.8

944

6593

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.6

25.8

557

3461

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.4

25.7

1202

8780

F02.39

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

261.2

25.7

H93.1

ICD-10 Finland

Tinnitus

1.5

25.6

718

4743

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

25.6

4994

44023

J34.2

ICD-10 Finland

Deviated nasal septum

1.7

25.6

492

2967

G04CB01

ATC

finasteride; oral

1.4

25.5

1021

7252

ZXE00

NOMESCO Finland

One hour or less

1.2

25.4

3970

34183

SPAT1252

SPAT

Overall medication plan or its review

1.6

25.3

696

4578

R03AC13

ATC

formoterol; inhalant

1.7

25.3

509

3105

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

3.3

25.2

296

L84

ICD-10 Finland

Corns and callosities

1.8

25.1

367

2046

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

4.6

25.1

129

R30.0

ICD-10 Finland

Dysuria

1.7

25.0

443

2612

AAG10

NOMESCO Finland

Stereotactic intracranial destruction of nucleus or nerve tract

+∞

25.0

AA40B, ,

NOMESCO Finland

4.1

25.0

167

P28

ICPC

Limited function/disability (P)

3.1

24.9

101

324

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

24.8

1372

10303

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.5

24.8

701

4639

IBB03

NOMESCO Finland

Assessment of vocational rehabilitation needs in a mental health context

5.2

24.8

L99

ICPC

Musculoskeletal disease other

2.0

24.7

256

1273

N27

ICPC

Fear of neurological disease other

2.2

24.7

207

949

K80

ICPC

Cardiac arrhythmia NOS

1.5

24.7

926

6496

D07AA02

ATC

hydrocortisone; topical

1.4

24.6

1314

9811

XF606

NOMESCO Finland

Ortostatic test

3.1

24.6

102

331

C07AB02

ATC

metoprolol; systemic

1.3

24.6

2054

16389

A02BA04

ATC

nizatidine; systemic

1.5

24.6

749

5040

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.5

24.5

150

599

T90

ICPC

Diabetes non-insulin dependent

1.3

24.5

2566

21080

-1, ,

NOMESCO Finland

1.3

24.4

3208

27063

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.2

24.4

199

903

F32.8

ICD-10 Finland

Other depressive episodes

2.4

24.3

165

691

G54.0

ICD-10 Finland

Brachial plexus disorders

2.1

24.3

241

1180

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

1.9

24.2

324

1758

H50.52

ICD-10 Finland

Exophoria

2.8

24.1

121

437

K03.66

ICD-10 Finland

Tooth plaque

1.5

24.1

787

5371

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

24.1

4067

35251

N06BA12

ATC

lisdexamfetamine; oral

3.1

24.1

320

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

2.9

24.0

110

378

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.4

24.0

1071

7755

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.7

24.0

400

2320

F20.9

ICD-10 Finland

Schizophrenia, unspecified

2.3

23.9

177

771

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

2.5

23.9

144

571

R83

ICPC

Respiratory infection other

1.3

23.9

2330

18964

R15

ICD-10 Finland

Faecal incontinence

1.8

23.9

329

1802

C10AA01

ATC

simvastatin; oral

1.2

23.8

4474

39192

R31

ICD-10 Finland

Unspecified haematuria

1.4

23.8

1021

7341

M01AX05

ATC

glucosamine; oral

1.3

23.8

2043

16354

N19

ICPC

Speech disorder

2.5

23.8

144

572

L11

ICPC

Wrist symptom/complaint

1.4

23.8

935

6617

N07CA01

ATC

betahistine; oral

1.5

23.7

749

5075

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

2.8

23.7

121

441

R49.01

ICD-10 Finland

Functional dysphonia

1.9

23.7

307

1648

IGV01

NOMESCO Finland

Psychiatric network contact

3.1

23.7

100

328

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

23.7

3837

33094

R26.0

ICD-10 Finland

Ataxic gait

5.1

23.5

A27

ICPC

Fear of other disease NOS

1.6

23.4

540

3412

XA402

NOMESCO Finland

ENMG

2.0

23.3

248

1245

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.0

23.3

246

1233

3007

Kela drug reimbursment

Erenumab and fremanezumab

2.7

23.3

123

457

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.4

23.2

1060

7708

OAA65, ,

SPAT

1.3

23.2

1487

11422

A07EA06

ATC

budesonide; oral, local oral

1.8

23.1

369

2113

ZXA00

NOMESCO Finland

Right side

1.3

23.1

2684

22300

ZY000

NOMESCO Finland

Hospital inpatient

2.7

23.1

123

459

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.6

23.0

562

3597

J02AC02

ATC

itraconazole; systemic

1.3

23.0

1735

13640

SPAT1284

SPAT

Extensive health certificate

2.0

23.0

255

1300

IEY01

NOMESCO Finland

Psychoeducation, individual

3.4

23.0

243

D02

ICPC

Abdominal pain epigastric

1.5

22.9

643

4250

TPH04

NOMESCO Finland

Cathetrisation of vein

1.3

22.9

2281

18604

M77.4

ICD-10 Finland

Metatarsalgia

1.6

22.9

606

3954

UJD02

NOMESCO Finland

Gastroscopy

1.6

22.8

477

2942

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

22.7

2316

18937

D07AD01

ATC

clobetasol; topical

1.3

22.7

1711

13447

K04.1

ICD-10 Finland

Necrosis of pulp

1.4

22.7

1037

7540

T83

ICPC

Overweight

2.1

22.7

225

1102

IEY05, ,

SPAT

5.5

22.7

N02CC05

ATC

almotriptan; oral

1.8

22.7

334

1868

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.4

22.6

1287

9702

K02.0

ICD-10 Finland

Caries limited to enamel

1.3

22.6

1839

14605

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.3

22.6

177

790

C10AC01

ATC

colestyramine; oral

1.9

22.6

294

1582

E000001, ,

ATC

1.3

22.6

1898

15143

M15

ICD-10 Finland

Polyarthrosis

1.6

22.5

553

3544

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.4

22.5

981

7073

J01FF01

ATC

clindamycin; systemic

1.3

22.5

2726

22749

E03

ICD-10 Finland

Other hypothyroidism

1.5

22.4

621

4091

G04BD11

ATC

fesoterodine; oral

1.9

22.4

300

1629

N02CC04

ATC

rizatriptan; oral

1.6

22.4

491

3063

IGY99, ,

SPAT

2.3

22.3

162

700

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.3

22.3

2296

18796

K58

ICD-10 Finland

Irritable bowel syndrome

1.9

22.2

262

1364

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

2.9

22.2

101

346

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

3.6

22.2

205

L82

ICD-10 Finland

Seborrhoeic keratosis

1.3

22.2

1985

15960

R07.0

ICD-10 Finland

Pain in throat

1.5

22.2

681

4587

J01FA09

ATC

clarithromycin; systemic

1.2

22.2

3090

26184

G24

ICD-10 Finland

Dystonia

27.3

22.2

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.5

22.2

756

5203

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.2

22.1

194

907

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.2

22.1

192

894

B37.0

ICD-10 Finland

Candidal stomatitis

2.5

22.0

133

528

SPAT1283

SPAT

Restricted health certificate

1.3

22.0

1357

10356

L09

ICPC

Arm symptom/complaint

1.6

21.9

498

3133

G21.0

ICD-10 Finland

Malignant neuroleptic syndrome

+∞

21.9

D07AB08

ATC

desonide; topical

1.4

21.9

1047

7673

H92.0

ICD-10 Finland

Otalgia

1.5

21.8

604

3978

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

21.8

1597

12495

R06.2

ICD-10 Finland

Wheezing

1.7

21.8

433

2634

R29

ICPC

Respiratory symptom/complaint other

1.5

21.8

682

4614

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

3.8

21.8

171

R03AK11

ATC

formoterol and fluticasone; inhalant

2.0

21.7

250

1292

G24.0

ICD-10 Finland

Drug-induced dystonia

80.3

21.7

SPAT1101

SPAT

Orthostatic test

1.7

21.6

446

2740

N06AX18

ATC

reboxetine; oral

2.6

21.6

126

492

R26

ICD-10 Finland

Abnormalities of gait and mobility

5.4

21.6

SGA01

NOMESCO Finland

Emergency treatment

1.3

21.6

1472

11402

J01MA12

ATC

levofloxacin; systemic

1.3

21.5

1853

14819

SPAT1237

SPAT

Psychotherapy

3.7

21.5

186

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.4

21.5

857

6081

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

3.2

21.4

259

E66.00

ICD-10 Finland

Metabolic syndrome

1.6

21.4

536

3451

ZYC01, ,

SPAT

1.4

21.3

1008

7370

SPAT1281

SPAT

Other administrative function

1.5

21.3

744

5145

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.1

21.3

190

894

R06AX13

ATC

loratadine; oral

1.3

21.3

1374

10558

188

Kela drug reimbursment

Psychosis requiring demanding treatment

2.9

21.3

328

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.4

21.2

928

6692

K04.08

ICD-10 Finland

Other specified pulpit

1.5

21.2

683

4647

U13

ICPC

Bladder symptom/complaint other

1.8

21.2

312

1745

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.4

21.2

958

6950

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.3

21.1

2306

18995

R39.1

ICD-10 Finland

Other difficulties with micturition

1.8

21.1

319

1799

Z00.8

ICD-10 Finland

Other general examinations

1.5

21.1

786

5506

K85

ICPC

Elevated blood pressure

1.3

21.1

1807

14442

IFB02

NOMESCO Finland

Transcranial magnetic stimulation (TMS)

5.3

21.0

IAA02, ,

SPAT

4.3

21.0

123

N02AJ13

ATC

tramadol and paracetamol; systemic

2.0

21.0

240

1238

XF404

NOMESCO Finland

Ambulatory ECG

1.4

20.9

860

6137

F22.0

ICD-10 Finland

Delusional disorder

2.3

20.8

150

646

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.2

20.8

2713

22794

R52.1

ICD-10 Finland

Chronic intractable pain

2.7

20.8

108

398

IAA01, ,

SPAT

3.2

20.8

264

DHB50

NOMESCO Finland

Turbinoplasty

2.0

20.7

231

1180

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.2

20.7

2727

22934

C08CA01

ATC

amlodipine; oral

1.2

20.7

4177

36701

C09CA06

ATC

candesartan; oral

1.3

20.7

2490

20734

S00.0

ICD-10 Finland

Superficial injury of scalp

1.9

20.7

246

1286

N02CC07

ATC

frovatriptan; oral

1.8

20.6

330

1892

J05AB01

ATC

aciclovir; systemic

1.3

20.6

2199

18053

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.4

20.6

947

6889

R01AD05

ATC

budesonide; nasal

1.5

20.6

705

4858

SPAT1167

SPAT

Insertion of urinary catheter

1.8

20.5

315

1784

D03

ICPC

Heartburn

1.7

20.5

388

2331

IAB01, ,

SPAT

3.5

20.5

202

X58

ICD-10 Finland

Exposure to other specified factors

1.3

20.4

1394

10793

N05CD02

ATC

nitrazepam; oral

2.2

20.4

164

741

M19.8

ICD-10 Finland

Other specified arthrosis

1.6

20.4

422

2596

IHZ07, ,

SPAT

3.1

20.3

278

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

2.5

20.2

125

503

M75

ICD-10 Finland

Shoulder lesions

1.6

20.1

435

2705

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.4

20.1

773

5448

ICB06, ,

NOMESCO Finland

3.4

20.0

215

R41.3

ICD-10 Finland

Other amnesia

1.8

20.0

312

1777

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.5

19.9

622

4204

R61.9

ICD-10 Finland

Hyperhidrosis, unspecified

2.3

19.9

142

609

H57.1

ICD-10 Finland

Ocular pain

1.7

19.9

372

2227

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.7

19.9

398

2426

EB1AA, ,

SPAT

1.5

19.9

604

4060

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.4

19.8

901

6540

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

3.0

19.8

282

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

2.1

19.8

190

920

IEY21

NOMESCO Finland

Other intensified psychiatric treatment

5.2

19.8

A85

ICPC

Adverse effect medical agent

2.4

19.8

135

568

R63.4

ICD-10 Finland

Abnormal weight loss

1.6

19.8

408

2507

SFA00

NOMESCO Finland

Small restoration

1.3

19.8

1363

10567

K04

ICPC

Palpitations/awareness of heart

1.5

19.7

543

3573

H02.3

ICD-10 Finland

Blepharochalasis

1.5

19.7

670

4608

R26.2

ICD-10 Finland

Difficulty in walking, not elsewhere classified

2.3

19.7

140

600

E03.89

ICD-10 Finland

Other specified hypothyroidism

1.6

19.7

409

2518

G56.2

ICD-10 Finland

Lesion of ulnar nerve

1.8

19.7

311

1778

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

2.8

19.6

354

N05AD03

ATC

melperone; systemic

2.6

19.6

114

445

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.6

19.6

471

3005

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

1.9

19.6

246

1310

F25.21

ICD-10 Finland

Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms

4.7

19.6

C09CA01

ATC

losartan; oral

1.2

19.5

2704

22847

SPAT1104

SPAT

Monitoring of emergency patient

1.5

19.4

631

4300

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.5

19.4

578

3869

S97

ICPC

Chronic ulcer skin

1.5

19.4

645

4417

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.3

19.4

1259

9674

A09

ICPC

Sweating problem

2.4

19.4

132

555

N05BA02

ATC

chlordiazepoxide; systemic

2.0

19.4

218

1118

M50.3

ICD-10 Finland

Other cervical disc degeneration

1.9

19.4

240

1272

F32.0

ICD-10 Finland

Mild depressive episode

1.9

19.4

249

1336

M35.7

ICD-10 Finland

Hypermobility syndrome

2.4

19.3

134

568

F05.9

ICD-10 Finland

Delirium, unspecified

2.0

19.3

220

1133

S20

ICPC

Corn/callosity

2.0

19.3

219

1127

R41.0

ICD-10 Finland

Disorientation, unspecified

1.8

19.3

304

1737

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.1

19.2

185

897

SPAT1251

SPAT

Organisation of medication

1.7

19.2

334

1961

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.5

19.2

585

3934

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.3

19.2

1524

12045

AA1BG, ,

SPAT

2.0

19.1

203

1020

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.6

19.1

419

2614

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

1.9

19.1

231

1214

G44.0

ICD-10 Finland

Cluster headache syndrome

2.6

19.1

110

428

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.4

19.0

956

7057

C03DA01

ATC

spironolactone; oral

1.3

19.0

1247

9593

S70.0

ICD-10 Finland

Contusion of hip

1.7

19.0

389

2385

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.3

19.0

1493

11780

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

19.0

1841

14923

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

2.8

19.0

349

F31.21

ICD-10 Finland

Bipolar disorder, manic episode with mood incongruent psychotic symptoms

6.0

19.0

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.6

18.9

421

2636

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

1.9

18.9

233

1233

X15

ICPC

Vaginal symptom/complaint other

1.7

18.9

347

2069

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

2.2

18.9

156

713

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.5

18.9

708

4965

J01MA06

ATC

norfloxacin; oral

1.3

18.8

1270

9810

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.2

18.8

2475

20780

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

1.7

18.8

309

1786

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

18.7

1951

15955

M01AB55

ATC

diclofenac, combinations; oral

1.5

18.7

651

4499

C01DA14

ATC

isosorbide mononitrate; oral

1.3

18.7

1543

12255

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

18.7

3486

30329

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.0

18.7

205

1043

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.6

18.7

438

2779

SPAT1139

SPAT

Nutrition survey

1.7

18.7

325

1910

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.3

18.7

141

621

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.4

18.7

132

565

G04CB02

ATC

dutasteride; oral

1.5

18.6

674

4692

ICC01

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric outpatient clinic

4.4

18.6

105

XKD03

NOMESCO Finland

Urethral pressure profilometry

1.9

18.6

232

1232

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.4

18.6

827

5979

TQW40, ,

SPAT

1.4

18.6

997

7437

IER01

NOMESCO Finland

Psychoeducation, group

3.3

18.6

215

IBB01

NOMESCO Finland

Psychiatric functioning capacity evaluation

4.2

18.5

118

ZXM20

NOMESCO Finland

Intraoperative use of computerised tomography

2.8

18.5

315

M70.7

ICD-10 Finland

Other bursitis of hip

1.8

18.5

273

1529

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.4

18.5

1046

7871

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.4

18.5

758

5404

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.2

18.4

2489

20954

F45.0

ICD-10 Finland

Somatization disorder

3.6

18.4

168

SXC05

NOMESCO Finland

Other oral or dental procedure

1.5

18.3

597

4072

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.7

18.3

317

1861

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

1.8

18.3

271

1521

DFF00

NOMESCO Finland

Pure tone audiometry

1.4

18.3

1057

7981

K29.7

ICD-10 Finland

Gastritis, unspecified

1.7

18.2

353

2135

AA5QN, ,

NOMESCO Finland

44.0

18.2

N04BC02

ATC

pergolide; oral

44.0

18.2

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

1.9

18.2

213

1108

K04.0

ICD-10 Finland

Pulpitis

1.4

18.2

769

5511

R10.2

ICD-10 Finland

Pelvic and perineal pain

1.9

18.2

235

1264

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

1.8

18.2

275

1553

H81.3

ICD-10 Finland

Other peripheral vertigo

1.8

18.1

289

1657

S16

ICPC

Bruise/contusion

1.7

18.1

320

1889

L18

ICPC

Muscle pain

1.6

18.1

417

2635

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.6

18.1

453

2919

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.4

18.1

1071

8115

SPAT1246

SPAT

Screening of depression or other psychiatric problem

1.7

18.1

322

1905

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.2

18.0

2474

20859

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.2

18.0

2422

20379

P98

ICPC

Psychosis NOS/other

3.2

17.9

215

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.5

17.9

620

4280

ZXA05

NOMESCO Finland

Left side

1.2

17.9

2437

20525

SPAT1050

SPAT

Extensive neurological examination

1.9

17.9

206

1066

WX402

NOMESCO Finland

General anaesthesia

1.2

17.9

2211

18428

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.3

17.9

1463

11603

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.6

17.8

423

2691

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.3

17.8

1171

9009

J01DA09

ATC

[U] cefadroxil

1.2

17.8

2520

21311

130

Kela drug reimbursment

Malignant tumour

0.6

17.8

426

6516

IFA01, ,

SPAT

4.4

17.7

101

G23.2

ICD-10 Finland

Multiple system atrophy, parkinsonian type [MSA-P]

+∞

17.7

A06AX04

ATC

linaclotide; oral

3.8

17.7

140

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.3

17.7

1157

8898

ICB01, ,

SPAT

2.7

17.7

346

M77.1

ICD-10 Finland

Lateral epicondylitis

1.4

17.6

694

4909

S20.2

ICD-10 Finland

Contusion of thorax

1.5

17.6

489

3225

Z97.2

ICD-10 Finland

Presence of dental prosthetic device (complete)(partial)

1.7

17.6

317

1881

M76.0

ICD-10 Finland

Gluteal tendinitis

1.9

17.5

223

1193

P27

ICPC

Fear of mental disorder

2.4

17.5

123

525

SPAT1051

SPAT

Guidance regarding sleep disorders

2.2

17.5

150

696

WX110, ,

SPAT

1.5

17.5

507

3374

D07AC13

ATC

mometasone; topical

1.2

17.5

2852

24458

R07.2

ICD-10 Finland

Precordial pain

1.9

17.5

212

1117

K08.3

ICD-10 Finland

Retained dental root

1.4

17.5

753

5416

UDQ42

NOMESCO Finland

Endoscopic assessment of swallowing function

4.1

17.4

115

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.6

17.4

441

2849

S10

ICPC

Boil/carbuncle

1.5

17.4

561

3818

S94

ICPC

Ingrowing nail

2.0

17.4

177

877

IER03

NOMESCO Finland

Psychiatric disorder-specific group intervention

4.2

17.4

111

AB5CT

NOMESCO Finland

Blockage of nerv root with CT guidance

2.7

17.4

332

C01CA01

ATC

etilefrine; systemic

3.0

17.3

256

G03FA01

ATC

norethisterone and estrogen; systemic

1.3

17.3

1331

10466

F48.0

ICD-10 Finland

Neurasthenia

4.5

17.2

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

2.4

17.2

111

456

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.6

17.2

438

2834

F60.5

ICD-10 Finland

Anankastic personality disorder

2.5

17.2

102

403

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

2.3

17.1

127

555

WX722

NOMESCO Finland

PEEP

1.6

17.1

420

2694

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

2.7

17.1

346

AA1CG, ,

SPAT

2.4

17.1

118

500

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

17.1

2449

20723

D18

ICPC

Change in faeces/bowel movements

1.8

17.1

274

1574

N05AH05

ATC

asenapine; oral

6.4

17.1

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.3

17.1

1175

9099

SPAT1262

SPAT

Handing over of treatment supplies

1.3

17.1

1686

13687

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.5

17.1

511

3426

F25.1

ICD-10 Finland

Schizoaffective disorder, depressive type

4.9

17.0

F25.11

ICD-10 Finland

Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms

4.8

17.0

TDA90, ,

SPAT

1.4

17.0

698

4976

S01.0

ICD-10 Finland

Open wound of scalp

1.4

16.9

741

5342

C01CA24

ATC

epinephrine; parenteral

1.5

16.9

532

3602

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.2

16.9

2083

17340

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

16.9

379

2380

R09

ICPC

Sinus symptom/complaint

1.4

16.9

744

5372

R03BC03

ATC

nedocromil; inhalant

1.4

16.8

635

4458

S80.0

ICD-10 Finland

Contusion of knee

1.4

16.8

709

5080

KCV04

NOMESCO Finland

Distension of bladder with fluid

2.5

16.8

101

402

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.3

16.8

1070

8196

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.6

16.7

419

2701

SPAT1241

SPAT

Extensive assessment of psychosocial situation

2.6

16.7

385

G03DB01

ATC

dydrogesterone; oral

1.3

16.7

1076

8253

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

2.5

16.6

104

422

C08CA13

ATC

lercanidipine; oral

1.3

16.6

1495

11999

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

2.4

16.6

116

495

R81

ICPC

Pneumonia

1.6

16.5

369

2314

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.4

16.5

868

6454

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

1.5

16.5

524

3557

R1250, ,

SPAT

1.7

16.4

305

1825

Z08

ICPC

Social welfare problem

2.3

16.4

128

572

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.5

16.4

552

3790

T82

ICPC

Obesity

1.6

16.4

371

2335

N02CD03

ATC

fremanezumab; systemic

2.7

16.4

314

R68.88

ICD-10 Finland

Other specified general symptoms and signs, not elsewhere classified.

2.8

16.4

303

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

2.1

16.4

144

676

G50.1

ICD-10 Finland

Atypical facial pain

2.0

16.3

175

884

H26.4

ICD-10 Finland

After-cataract

1.3

16.3

1077

8288

WZC30, ,

SPAT

1.4

16.3

834

6173

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

1.4

16.3

621

4368

R01AD59

ATC

mometasone, combinations; nasal

1.5

16.2

567

3921

F05

ICPC

Visual disturbance other

1.7

16.2

327

1999

F51.2

ICD-10 Finland

Nonorganic disorder of the sleep-wake schedule

3.0

16.2

234

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.4

16.2

804

5922

R75

ICPC

Sinusitis acute/chronic

1.5

16.2

445

2929

R40.0

ICD-10 Finland

Somnolence

3.9

16.1

122

R4130, ,

SPAT

3.6

16.1

145

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

1.6

16.1

359

2253

ZXH06, ,

SPAT

1.5

16.0

469

3129

EB1MA

NOMESCO Finland

Cephalometry with X-ray

2.0

16.0

166

829

K29

ICPC

Cardiovascular sympt/complt other

1.5

16.0

449

2969

P02

ICPC

Acute stress reaction

1.5

16.0

426

2786

OAB42, ,

SPAT

1.3

16.0

1238

9742

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

2.2

16.0

128

579

SXC06

NOMESCO Finland

Clinical work to produce sleep apnoea splint

3.4

15.9

170

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.3

15.9

962

7307

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.4

15.9

664

4747

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.6

15.9

343

2135

G01AF05

ATC

econazole; vaginal

1.4

15.9

669

4793

I95.9

ICD-10 Finland

Hypotension, unspecified

2.1

15.9

154

751

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.2

15.8

2244

18950

R01AD11

ATC

triamcinolone; nasal

1.4

15.8

775

5700

K13.78

ICD-10 Finland

Other change in the oral mucosa

1.7

15.7

260

1507

F61

ICD-10 Finland

Mixed and other personality disorders

3.6

15.7

138

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

1.8

15.7

238

1346

G50.0

ICD-10 Finland

Trigeminal neuralgia

2.0

15.7

174

890

F44.4

ICD-10 Finland

Dissociative motor disorders

6.9

15.7

IFA37

NOMESCO Finland

Ketamine treatment

7.2

15.7

ACC51

NOMESCO Finland

Release of median nerve

1.4

15.6

713

5177

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

1.6

15.6

331

2051

G43.8

ICD-10 Finland

Other migraine

2.1

15.6

139

656

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.4

15.6

634

4513

I50

ICD-10 Finland

Heart failure

1.7

15.6

302

1829

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.3

15.6

1106

8599

XG474

NOMESCO Finland

Exhalation nntrogen oxide

1.8

15.5

229

1285

S01

ICPC

Pain/tenderness of skin

1.5

15.4

459

3074

R25.3

ICD-10 Finland

Fasciculation

3.4

15.4

164

F25.2

ICD-10 Finland

Schizoaffective disorder, mixed type

4.8

15.4

SPAT1210

SPAT

Application of cast or individual aid

1.6

15.4

374

2395

-, ,

ICD-10 Finland

1.8

15.4

210

1151

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

2.1

15.3

138

654

R19.5

ICD-10 Finland

Other faecal abnormalities

1.9

15.3

180

940

R09.1

ICD-10 Finland

Pleurisy

2.0

15.3

171

878

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

2.4

15.2

101

421

UJD10, ,

SPAT

1.7

15.2

254

1477

IAB14

NOMESCO Finland

Geriatric psychiatry consultation

5.0

15.2

N07BA03

ATC

varenicline; oral

1.5

15.2

404

2642

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.3

15.1

1661

13637

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.2

15.1

3451

30451

H25.1

ICD-10 Finland

Senile nuclear cataract

1.2

15.1

2930

25483

R25

ICD-10 Finland

Abnormal involuntary movements

17.7

15.1

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.6

15.1

353

2240

183

Kela drug reimbursment

Lamotrigin and topiramate

2.6

15.1

322

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

5.3

15.1

F06.7

ICD-10 Finland

Mild cognitive disorder

1.7

15.1

301

1837

I20.09

ICD-10 Finland

Unstable angina

1.5

15.1

526

3638

R06.4

ICD-10 Finland

Hyperventilation

2.1

15.1

142

685

N04AA01

ATC

trihexyphenidyl; oral

20.0

15.1

F51.1

ICD-10 Finland

Nonorganic hypersomnia

5.6

15.0

N03AX14

ATC

levetiracetam; systemic

1.7

15.0

264

1557

SPAT1244

SPAT

Occupational therapy

2.4

15.0

105

448

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.3

15.0

1094

8533

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.4

15.0

843

6332

L20

ICPC

Joint symptom/complaint NOS

1.6

15.0

375

2417

P15

ICPC

Chronic alcohol abuse

1.8

15.0

242

1394

N02CD01

ATC

erenumab; parenteral

2.7

15.0

278

B80

ICPC

Iron deficiency anaemia

1.7

15.0

255

1492

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.0

15.0

164

836

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

1.8

15.0

205

1125

R07

ICPC

Sneezing/nasal congestion

1.4

14.9

557

3902

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

2.3

14.9

115

512

AEA20

NOMESCO Finland

Removal of impulse generator of stimulation device in the nervous system

5.4

14.9

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

1.9

14.9

193

1040

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.7

14.9

285

1720

A01AB10

ATC

natamycin; local oral

1.7

14.9

262

1547

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.4

14.9

706

5163

A46

ICD-10 Finland

Erysipelas

1.3

14.8

1451

11752

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

2.0

14.8

154

770

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

2.5

14.8

384

SPAT1377

SPAT

Polysomnography

1.7

14.8

293

1784

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

1.7

14.8

293

1784

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

2.1

14.8

144

703

SPAT1285

SPAT

Provision of consultation response

1.5

14.8

484

3305

AAW01

NOMESCO Finland

Implantation of intracranial stimulation device

56.7

14.8

R1430, ,

SPAT

2.0

14.8

158

799

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

1.6

14.7

380

2467

OAB38, ,

SPAT

2.1

14.7

134

638

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

3.1

14.7

189

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.4

14.7

660

4779

M20.1

ICD-10 Finland

Hallux valgus (acquired)

1.4

14.7

809

6058

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

2.9

14.7

237

T86

ICPC

Hypothyroidism/myxoedema

1.5

14.7

440

2953

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.5

14.6

397

2608

F02.32

ICD-10 Finland

Dementia in Parkinson's disease other additional symptoms, mainly hallucinations

+∞

14.6

N05AB01

ATC

dixyrazine; systemic

2.3

14.6

110

486

A23

ICPC

Risk factor NOS

1.3

14.5

868

6581

K02

ICD-10 Finland

Dental caries

1.4

14.5

601

4291

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

1.6

14.5

380

2476

XA420

NOMESCO Finland

Extensive sleep examination

2.3

14.5

102

437

M01AX01

ATC

nabumetone; oral

1.5

14.5

386

2525

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

2.2

14.5

124

577

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.4

14.5

582

4135

AA1BD

NOMESCO Finland

Extensive CT of head and brain

1.8

14.4

229

1313

G11.9

ICD-10 Finland

Hereditary ataxia, unspecified

5.4

14.4

K44

ICD-10 Finland

Diaphragmatic hernia

2.4

14.4

395

IDY30, ,

NOMESCO Finland

36.0

14.4

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.5

14.4

459

3118

E66

ICD-10 Finland

Obesity

1.5

14.4

468

3192

N02CD02

ATC

galcanezumab; parenteral

3.5

14.4

137

R23.3

ICD-10 Finland

Spontaneous ecchymoses

1.8

14.4

214

1205

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

1.8

14.3

196

1075

M01AH03

ATC

valdecoxib; oral

1.4

14.3

548

3857

G03DC03

ATC

lynestrenol; oral

1.9

14.3

178

947

K11.70

ICD-10 Finland

Hypoptyalism

2.7

14.3

279

WW200, ,

SPAT

1.2

14.3

3062

26843

SPAT1336

SPAT

Request for examination

1.6

14.3

329

2080

ZXD20

NOMESCO Finland

Day surgery

1.3

14.3

1167

9239

D25

ICPC

Abdominal distension

1.8

14.3

192

1047

G01AA10

ATC

clindamycin; vaginal

1.3

14.3

1257

10047

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.5

14.2

147

2802

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

1.8

14.2

198

1092

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.0

14.2

156

796

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

1.8

14.2

194

1064

WX320

NOMESCO Finland

Spinalanesthesy

1.2

14.2

2487

21413

D06AX01

ATC

fusidic acid; topical

1.4

14.2

811

6110

SCA02

NOMESCO Finland

Preventive oral health care

1.3

14.1

877

6686

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.1

14.1

132

635

NA1BG, ,

SPAT

1.9

14.1

163

846

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.3

14.1

886

6766

K03.00

ICD-10 Finland

Approximal wear

1.4

14.1

699

5148

IEY02

NOMESCO Finland

Intensified psychiatric outpatient care, Assertive Community Treatment (ACT)

3.8

14.1

111

N02CC06

ATC

eletriptan; oral

1.7

14.1

275

1670

R03AC12

ATC

salmeterol; inhalant

1.5

14.0

405

2696

N02CD06

ATC

rimegepant; oral

3.0

14.0

200

F25.01

ICD-10 Finland

Schizoaffective syndrome, manic type with prolonged schizophrenic than bipolar symptoms

4.3

14.0

T05

ICPC

Feeding problem of adult

2.4

13.9

365

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

1.5

13.9

418

2806

SPAT1238

SPAT

Brief therapy

2.1

13.9

134

653

T07

ICPC

Weight gain

2.0

13.9

138

680

OAB50, ,

SPAT

1.4

13.8

791

5957

M02AA15

ATC

diclofenac; topical

1.4

13.8

663

4855

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.4

13.8

588

4219

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

2.7

13.8

273

R52.0

ICD-10 Finland

Acute pain

1.6

13.8

296

1841

A07DA03

ATC

loperamide; oral

1.6

13.8

306

1919

R44.0

ICD-10 Finland

Auditory hallucinations

3.1

13.8

176

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.5

13.8

459

3148

N48.1

ICD-10 Finland

Balanoposthitis

1.8

13.8

208

1177

T78.4

ICD-10 Finland

Allergy, unspecified

1.5

13.7

389

2579

R04

ICPC

Breathing problem other

1.5

13.7

367

2403

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

2.0

13.7

137

676

IGP01

NOMESCO Finland

Psychiatric family contact

2.9

13.7

224

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

3.0

13.7

192

N77.1*B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

1.9

13.7

179

968

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.3

13.7

917

7067

K05.1

ICD-10 Finland

Chronic gingivitis

1.4

13.7

596

4294

R08

ICPC

Nose symptom/complaint other

1.6

13.7

320

2033

G72.9

ICD-10 Finland

Myopathy, unspecified

2.5

13.7

321

N05AF05

ATC

zuclopenthixol; systemic

2.5

13.7

321

IBA02

NOMESCO Finland

Evaluation of need for psychiatric rehabilitation

3.1

13.7

177

H02.4

ICD-10 Finland

Ptosis of eyelid

1.6

13.6

279

1715

C08CA05

ATC

nifedipine; systemic

1.4

13.6

548

3894

J37.0

ICD-10 Finland

Chronic laryngitis

1.6

13.6

301

1886

K59.9

ICD-10 Finland

Functional intestinal disorder, unspecified

2.0

13.6

149

760

A10BJ02

ATC

liraglutide; parenteral

1.7

13.6

258

1555

DAX08

NOMESCO Finland

Fitting of hearing aid

1.4

13.6

572

4097

M19.9

ICD-10 Finland

Arthrosis, unspecified

1.5

13.6

423

2861

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.5

13.6

464

3197

K05.30

ICD-10 Finland

Periodontitis complex

1.3

13.6

1455

11905

J01AA04

ATC

lymecycline; systemic

1.3

13.6

1112

8808

G25.4

ICD-10 Finland

Drug-induced chorea

+∞

13.5

ZXY49

NOMESCO Finland

Other health care provider

3.6

13.5

119

R61

ICD-10 Finland

Hyperhidrosis

2.3

13.5

102

451

OAB44, ,

SPAT

1.3

13.5

888

6828

N05AX16

ATC

brexpiprazole; oral

4.0

13.5

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

1.8

13.5

183

1002

S82

ICPC

Naevus/mole

1.3

13.5

1363

11077

XG410

NOMESCO Finland

Flow-volume spirometry

1.6

13.4

351

2287

PA6AD

NOMESCO Finland

CT of neck arteries

1.5

13.4

356

2327

WZB00, ,

SPAT

1.3

13.4

783

5917

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

2.2

13.4

115

536

G44.8

ICD-10 Finland

Other specified headache syndromes

2.0

13.4

132

649

F60.8

ICD-10 Finland

Other specific personality disorders

2.9

13.3

206

J01AA07

ATC

tetracycline; systemic

1.3

13.3

1260

10159

K07.4

ICD-10 Finland

Malocclusion, unspecified

2.0

13.3

145

739

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

1.6

13.3

305

1929

YX8AD

NOMESCO Finland

Stereotactic CT examination for dose design of radiotherapy

6.3

13.3

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

1.7

13.2

217

1257

J45.8

ICD-10 Finland

Mixed asthma

1.6

13.2

279

1728

ZYB04

NOMESCO Finland

Outreach service in patient’s home or everyday environment

3.4

13.2

140

H02AB02

ATC

dexamethasone; systemic

0.7

13.2

667

8914

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

2.3

13.2

424

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.4

13.2

718

5367

H61.2

ICD-10 Finland

Impacted cerumen

1.4

13.2

664

4904

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

1.6

13.2

327

2107

L90

ICPC

Osteoarthrosis of knee

1.4

13.2

686

5094

F43.29

ICD-10 Finland

Adaptation disorder UNS

1.8

13.2

186

1032

N94.1

ICD-10 Finland

Dyspareunia

2.2

13.2

104

469

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

1.7

13.1

257

1562

N81.6

ICD-10 Finland

Rectocele

1.4

13.1

629

4607

R63.1

ICD-10 Finland

Polydipsia

3.9

13.1

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.6

13.1

332

2148

A10BK03

ATC

empagliflozin; oral

1.3

13.1

986

7722

R5599

NOMESCO Finland

Other rehabilitation service

1.7

13.1

247

1487

Z29

ICPC

Social problem NOS

1.8

13.1

188

1048

E29.1

ICD-10 Finland

Testicular hypofunction

2.3

13.0

439

M15.8

ICD-10 Finland

Other polyarthrosis

1.7

13.0

210

1211

B01AC04

ATC

clopidogrel; oral

1.2

13.0

1597

13258

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

1.6

13.0

303

1923

N05

ICPC

Tingling fingers/feet/toes

2.1

13.0

122

589

2957A

ICD-9 Finland

Schizophrenic psychoses, Schizo-affective type

4.1

13.0

TKC20

NOMESCO Finland

Catheterisation of bladder

1.4

13.0

614

4488

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

1.9

13.0

167

900

29580

ICD-8 Finland

Schizophrenia, Other

3.4

13.0

137

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.5

12.9

369

2451

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

1.5

12.9

381

2548

A10BA02

ATC

metformin; oral

1.2

12.9

2806

24592

F01

ICPC

Eye pain

1.6

12.9

269

1661

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.5

12.9

429

2940

C10AX09

ATC

ezetimibe; oral

1.2

12.9

1674

13980

UJH02

NOMESCO Finland

Anoscopy

1.5

12.9

372

2477

SBA00

NOMESCO Finland

Microbiological examinations

1.7

12.9

236

1410

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

2.2

12.9

108

499

J01FA15

ATC

telithromycin; oral

1.3

12.8

859

6621

XA421

NOMESCO Finland

Nocturnal polygraphy

2.8

12.8

216

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.6

12.8

321

2072

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.6

12.8

273

1696

N41.1

ICD-10 Finland

Chronic prostatitis

1.8

12.7

194

1101

R1420, ,

SPAT

2.8

12.7

228

UDM02

NOMESCO Finland

Sinoscopy

1.8

12.7

196

1116

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

1.8

12.7

192

1087

EBA30

NOMESCO Finland

Extraction of root of tooth

1.4

12.6

533

3820

-50

ICPC

Medication/prescr/renewal

1.5

12.6

368

2456

EBA10

NOMESCO Finland

Operative extraction of tooth

1.3

12.6

1021

8072

R01AX03

ATC

ipratropium bromide; nasal

1.8

12.6

194

1104

H91.9

ICD-10 Finland

Hearing loss, unspecified

1.4

12.6

485

3419

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

3.1

12.6

170

D01AE16

ATC

amorolfine; topical

1.3

12.6

1081

8611

B07.9

ICD-10 Finland

Verruca simplex

1.6

12.6

311

2002

L57.0

ICD-10 Finland

Actinic keratosis

1.3

12.6

1083

8632

ICB03, ,

SPAT

3.6

12.5

111

D50

ICD-10 Finland

Iron deficiency anaemia

1.7

12.5

208

1210

M13.9

ICD-10 Finland

Arthritis, unspecified

1.4

12.5

686

5133

A60

ICPC

General and Unspecified, Result test/procedure

1.5

12.5

396

2688

D06BX01

ATC

metronidazole; topical

1.3

12.5

977

7688

R1100, ,

SPAT

2.0

12.5

133

672

E86

ICD-10 Finland

Volume depletion

1.7

12.5

225

1338

R68.2

ICD-10 Finland

Dry mouth, unspecified

2.4

12.5

347

F0232, G20,

ICD-10 Finland

+∞

12.5

G24.2

ICD-10 Finland

Idiopathic nonfamilial dystonia

+∞

12.5

3320A

ICD-9 Finland

Parkinson's disease, Paralysis agitans

+∞

12.5

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.4

12.5

707

5317

I50.9

ICD-10 Finland

Heart failure, unspecified

1.2

12.5

1367

11207

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

2.0

12.5

132

666

N02CC03

ATC

zolmitriptan; nasal, oral

1.5

12.5

421

2896

E87.6

ICD-10 Finland

Hypokalaemia

1.5

12.5

325

2118

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.5

12.4

383

2586

N07XX06

ATC

tetrabenazine; oral

130.1

12.4

C08DA01

ATC

verapamil; systemic

1.5

12.4

370

2481

U08

ICPC

Urinary retention

1.8

12.4

196

1124

S09

ICPC

Infected finger/toe

1.6

12.4

292

1858

U29

ICPC

Urinary symptom/complaint other

1.6

12.4

296

1890

I45.9

ICD-10 Finland

Conduction disorder, unspecified

2.3

12.4

398

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

2.3

12.4

398

P58

ICPC

Psychological, Therapeutic counselling/listening

1.9

12.4

157

842

R39.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the urinary system

2.4

12.4

367

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

1.6

12.4

287

1821

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

2.4

12.4

331

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.5

12.3

410

2811

A02BA03

ATC

famotidine; systemic

1.6

12.3

319

2075

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.3

12.3

844

6526

Z63.0

ICD-10 Finland

Problems in relationship with spouse or partner

2.5

12.3

290

TCC40

NOMESCO Finland

Closure of lacrimal canaliculus with plug

3.6

12.3

108

P80

ICPC

Personality disorder

3.2

12.3

142

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

1.9

12.2

144

754

F10.24

ICD-10 Finland

Alcohol depence active use

2.0

12.2

121

597

R44.3

ICD-10 Finland

Hallucinations, unspecified

2.8

12.2

217

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

2.2

12.1

100

459

B35.1

ICD-10 Finland

Tinea unguium

1.4

12.1

613

4529

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

1.8

12.1

183

1036

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.4

12.1

522

3756

M05BA04

ATC

alendronic acid; oral

1.3

12.1

858

6665

B01AF02

ATC

apixaban; oral

1.2

12.1

1367

11243

X14

ICPC

Vaginal discharge

1.8

12.1

170

942

J05AB11

ATC

valaciclovir; oral

1.2

12.1

1389

11445

H82

ICPC

Vertiginous syndrome

1.8

12.1

175

979

G81.9

ICD-10 Finland

Hemiplegia, unspecified

2.2

12.1

428

L87

ICPC

Bursitis/tendinitis/synovitis NOS

1.9

12.1

142

744

SPAT1235

SPAT

Mental health, emotional support

2.6

12.0

252

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.3

12.0

913

7160

D07XC01

ATC

betamethasone; topical

1.3

12.0

1081

8664

H60.8

ICD-10 Finland

Other otitis externa

1.6

12.0

281

1788

SPA02

NOMESCO Finland

Preparation for dental prosthetics

1.6

12.0

305

1978

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.3

12.0

802

6183

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.4

12.0

446

3127

F06.0

ICD-10 Finland

Organic hallucinosis

4.2

12.0

AXX01, ,

SPAT

1.5

12.0

408

2813

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

1.6

11.9

281

1789

NA3AA, ,

SPAT

1.5

11.9

341

2267

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

1.6

11.9

300

1940

K05.18

ICD-10 Finland

Chronic gingivitis

1.4

11.9

647

4836

N02AC04

ATC

dextropropoxyphene; oral

1.5

11.9

313

2044

A02BX02

ATC

sucralfate; oral

1.5

11.9

345

2301

UDC00

NOMESCO Finland

Ear microscopy

1.3

11.9

673

5062

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

1.4

11.9

473

3356

AA1AA

NOMESCO Finland

Head X-ray examination

2.4

11.9

337

NA3BG, ,

SPAT

1.5

11.9

345

2302

L50.3

ICD-10 Finland

Dermatographic urticaria

1.9

11.8

148

791

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

1.9

11.8

145

770

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.2

11.8

1498

12474

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

2.2

11.8

458

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

1.9

11.8

133

687

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.4

11.8

554

4047

X72

ICPC

Genital candidiasis female

2.3

11.8

401

I73.0

ICD-10 Finland

Raynaud syndrome

1.9

11.8

151

814

F45.9

ICD-10 Finland

Somatoform disorder, unspecified

3.6

11.7

102

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.3

11.7

850

6625

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

1.5

11.7

404

2792

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

2.0

11.7

130

668

R23

ICPC

Voice symptom/complaint

1.7

11.7

203

1197

N18

ICPC

Paralysis/weakness

1.8

11.7

182

1041

M99.3

ICD-10 Finland

Osseous stenosis of neural canal

2.9

11.7

178

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

1.6

11.6

273

1737

D01BA02

ATC

terbinafine; oral

1.2

11.6

2440

21298

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

3.4

11.6

117

SCA03

NOMESCO Finland

Preventive oral health care, extensive

1.5

11.6

381

2607

F28

ICD-10 Finland

Other nonorganic psychotic disorders

3.8

11.6

D07CC01

ATC

betamethasone and antibiotics; topical

1.3

11.6

1094

8814

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

1.9

11.6

138

726

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

1.8

11.6

181

1036

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.4

11.6

446

3148

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.5

11.5

385

2644

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

0.6

11.5

143

2573

L29.8

ICD-10 Finland

Other pruritus

1.9

11.5

134

700

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

1.5

11.5

297

1933

Z73.6

ICD-10 Finland

Limitation of activities due to disability

2.3

11.5

355

R2130, ,

SPAT

1.8

11.5

158

871

F0230, G20,

ICD-10 Finland

+∞

11.5

G24.1

ICD-10 Finland

Idiopathic familial dystonia

+∞

11.5

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.4

11.5

562

4134

K04.09

ICD-10 Finland

Pulpit UNS

1.5

11.4

362

2459

D02AE01

ATC

carbamide; topical

1.4

11.4

550

4032

B82

ICPC

Anaemia other/unspecified

1.6

11.4

277

1776

WX290, ,

SPAT

1.6

11.4

269

1713

Z72.0

ICD-10 Finland

Tobacco use

1.7

11.4

219

1327

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.5

11.4

300

1961

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

1.9

11.4

128

661

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

1.5

11.4

351

2373

W10

ICD-10 Finland

Fall on and from stairs and steps

1.4

11.4

470

3359

M01AB08

ATC

etodolac; oral

1.4

11.4

627

4699

IAB07

NOMESCO Finland

Consultation concerning a patient with self-harm intention

3.7

11.4

XCK00

NOMESCO Finland

Perimetry

1.4

11.4

574

4243

SFC92

NOMESCO Finland

Other complicated additional procedure necessary for restorative treatment

1.4

11.3

578

4278

IEY06

NOMESCO Finland

Psychiatric treatment and rehabilitation coaching

3.8

11.3

R49.09

ICD-10 Finland

Unspecified dysphonia

2.1

11.3

107

519

SPAT1257

SPAT

Teaching of medicine inhalation technique

1.5

11.3

313

2069

S14

ICPC

Burn/scald

1.5

11.3

300

1965

G90.3

ICD-10 Finland

Multi-system degeneration

15.0

11.3

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

2.6

11.3

249

AN1

Coronary angiography

1.3

11.2

993

7937

IEV99

NOMESCO Finland

Other psychiatric network intervention

3.1

11.2

150

B03BA03

ATC

hydroxocobalamin; parenteral

1.4

11.2

511

3714

J35.0

ICD-10 Finland

Chronic tonsillitis

1.5

11.2

366

2504

M79.9

ICD-10 Finland

Soft tissue disorder, unspecified

2.2

11.2

410

S09.9

ICD-10 Finland

Unspecified injury of head

1.9

11.2

146

792

SPAT1106

SPAT

Acupuncture

2.4

11.2

316

TKC22

NOMESCO Finland

Catheterisation instruction

1.7

11.2

200

1190

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.4

11.2

567

4195

K14.61

ICD-10 Finland

Glossodynia

2.2

11.1

398

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.2

11.1

2117

18317

S01GX08

ATC

ketotifen; ophthalmic

1.5

11.1

371

2548

WVA20, ,

SPAT

1.5

11.1

324

2165

ZY010, ,

SPAT

1.9

11.1

134

709

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.5

11.1

372

2558

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

1.6

11.1

242

1515

N07

ICPC

Convulsion/seizure

3.9

11.1

R99

ICPC

Respiratory disease other

1.8

11.0

169

962

G51.3

ICD-10 Finland

Clonic hemifacial spasm

4.2

11.0

S76

ICPC

Skin infection other

1.4

11.0

497

3605

L10

ICPC

Elbow symptom/complaint

1.4

11.0

462

3310

G40

ICD-10 Finland

Epilepsy

2.3

11.0

368

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

1.5

11.0

323

2162

C10AA03

ATC

pravastatin; oral

1.3

11.0

667

5072

Z30.0

ICD-10 Finland

General counselling and advice on contraception

1.5

11.0

338

2285

XJH00

NOMESCO Finland

Transanal ultrasonography

1.4

10.9

493

3576

S06

ICPC

Rash localized

1.4

10.9

516

3772

CBB11

NOMESCO Finland

Resection of lax skin in upper eyelid

1.6

10.9

257

1638

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

1.7

10.9

181

1055

H60

ICD-10 Finland

Otitis externa

1.4

10.9

443

3157

J34.8

ICD-10 Finland

Other specified disorders of nose and nasal sinuses

2.0

10.9

106

520

D10

ICPC

Vomiting

1.4

10.9

450

3217

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

1.6

10.9

267

1719

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

1.7

10.9

208

1260

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

1.8

10.9

166

945

R20.8

ICD-10 Finland

Other and unspecified disturbances of skin sensation

2.1

10.9

102

494

R49.8

ICD-10 Finland

Other and unspecified voice disturbances

2.0

10.8

115

582

Z50.1

ICD-10 Finland

Other physical therapy

1.4

10.8

467

3362

S92.3

ICD-10 Finland

Fracture of metatarsal bone

1.5

10.8

289

1895

M01AB01

ATC

indometacin; systemic, rectal

1.3

10.8

640

4847

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

1.8

10.8

156

873

IEY03

NOMESCO Finland

Vocational rehabilitation

3.9

10.8

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.3

10.8

853

6726

N30.1

ICD-10 Finland

Interstitial cystitis (chronic)

2.0

10.8

108

536

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.4

10.7

432

3073

J01DA08

ATC

[U] cefaclor

1.3

10.7

836

6577

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.3

10.7

841

6622

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.3

10.7

601

4515

WZA00

NOMESCO Finland

Concise certificate

1.4

10.7

550

4076

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.3

10.7

1031

8325

A10BK01

ATC

dapagliflozin; oral

1.3

10.7

728

5624

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.3

10.7

598

4490

L01BC06

ATC

capecitabine; oral

0.6

10.7

140

2481

H91.1

ICD-10 Finland

Presbycusis

1.3

10.7

642

4872

A92

ICPC

Allergy/allergic reaction NOS

1.6

10.7

250

1591

SPAT1276

SPAT

Outlining of treatment with patient or their family members

1.7

10.7

197

1182

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.5

10.7

285

1870

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

2.0

10.7

104

511

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.5

10.6

297

1967

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.3

10.6

926

7388

J01MA14

ATC

moxifloxacin; systemic

1.3

10.6

796

6230

M75.8

ICD-10 Finland

Other shoulder lesions

1.5

10.6

340

2317

D10AX03

ATC

azelaic acid; topical

1.4

10.6

489

3562

F51.8

ICD-10 Finland

Other nonorganic sleep disorders

2.5

10.6

257

E000002, ,

ATC

1.3

10.6

918

7321

E000006, ,

ATC

1.3

10.6

594

4464

H81.9

ICD-10 Finland

Disorder of vestibular function, unspecified

1.9

10.6

124

650

P18

ICPC

Medication abuse

2.6

10.6

228

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.3

10.6

598

4500

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.4

10.6

440

3150

G40.39

ICD-10 Finland

Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures

3.1

10.5

140

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

1.3

10.5

654

4988

IHZ19, ,

SPAT

2.4

10.5

294

ZA1.0

ICD-10 Finland

Shoulder region

1.6

10.5

221

1371

K03.28

ICD-10 Finland

Other erosion of teeth

1.6

10.5

211

1294

WX892

NOMESCO Finland

Monitored bed care

1.3

10.5

677

5191

IFA99, ,

SPAT

3.2

10.5

125

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.4

10.5

411

2910

G03HB01

ATC

cyproterone and estrogen; oral

1.3

10.5

662

5062

J30.0

ICD-10 Finland

Vasomotor rhinitis

1.6

10.5

238

1505

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

1.7

10.5

193

1158

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.2

10.5

2231

19481

EB1HA, ,

SPAT

1.6

10.5

226

1412

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

2.7

10.5

195

103

Kela drug reimbursment

Diabetes, insulin-treated

1.2

10.5

2602

23003

ICZ04

NOMESCO Finland

Preparation of psychiatric treatment plan

3.8

10.4

ACC53

NOMESCO Finland

Release of ulnar nerve

1.9

10.4

122

639

G24.4

ICD-10 Finland

Idiopathic orofacial dystonia

110.1

10.4

G26

ICD-10 Finland

Extrapyramidal and movement disorders in diseases classified elsewhere

+∞

10.4

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.2

10.4

1766

15118

M43.0

ICD-10 Finland

Spondylolysis

1.8

10.4

150

840

R95

ICPC

Chron obstructive pulmonary disease

1.6

10.4

266

1729

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

1.5

10.4

285

1881

NAG41

NOMESCO Finland

Anterior fusion of cervical spine with fixation

2.7

10.4

196

S89.9

ICD-10 Finland

Unspecified injury of lower leg

1.5

10.3

291

1931

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.3

10.3

946

7594

WVA30, ,

SPAT

1.3

10.3

615

4663

A10BH01

ATC

sitagliptin; oral

1.3

10.3

867

6887

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3001122) Ferritin [Mass/volume] in Serum or Plasma

7988

51570

2.62

307.65

3.9

3.2

109.63

128.83

ug/l

13.86

7375

48028

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

7563

50390

2.34

307.65

2.6

2.2

96.96

96.34

pmol/l

0.50

4142

26444

(3021960) Folate [Moles/volume] in Serum or Plasma

5583

33193

2.27

307.65

1.9

1.7

20.04

20.31

nmol/l

0.63

4821

28092

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

5568

35139

2.08

307.65

2.5

2.2

185.31

207.25

u/l

1.29

5264

33150

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4908

30341

2.04

295.74

2.6

2.4

2.66

2.85

mg/l

7.96

4188

26332

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

7874

57842

2.03

286.55

7.1

7.4

1.22

1.21

mmol/l

3.46

6888

49868

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

7190

51707

1.96

271.16

6.6

6.7

1.21

mmol/l

2.16

6673

47750

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

10143

82974

2.38

265.91

5.7

4.5

14.90

14.84

pmol/l

1.63

9380

76157

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

9910

80520

2.27

260.06

5.2

4.6

11.64

12.81

mm/h

14.37

9306

75302

(3015377) Calcium [Moles/volume] in Serum or Plasma

5760

39601

1.87

236.74

3.0

3.6

2.35

2.36

mmol/l

0.50

5167

35906

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

11173

97565

2.90

220.34

7.4

5.6

1.84

1.94

mu/l

15.19

10466

90184

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

10053

84027

2.16

215.88

8.5

8.6

77.25

79.82

u/l

7.53

9582

79796

(3022948) Iron [Moles/volume] in Serum or Plasma

3410

20242

1.95

215.84

2.5

2.7

13.79

12.65

umol/l

15.74

3118

18806

(3024561) Albumin [Mass/volume] in Serum or Plasma

6927

51551

1.80

209.41

4.8

5.1

35.99

35.43

g/l

15.09

6492

48271

(3004789) Transferrin [Mass/volume] in Serum or Plasma

3185

18905

1.93

198.92

2.5

2.6

2.38

2.31

g/l

9.52

2882

17448

(3031040) Bacteria [#/volume] in Urine by Automated count

8942

72617

1.89

195.57

6.4

4.9

1958.10

1872.01

e6/l

0.04

124

1015

(3019309) Folate [Moles/volume] in Red Blood Cells

3284

19845

1.90

193.30

1.9

1.7

1186.46

1159.82

nmol/l

0.81

2495

14936

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

6815

51186

1.76

192.40

2.8

2.5

78.39

78.34

nmol/l

0.04

6156

46228

(3012095) Magnesium [Moles/volume] in Serum or Plasma

3202

19324

1.89

188.44

2.7

3.4

0.82

0.81

mmol/l

5.73

2963

18204

(3037467) Urinalysis macro (dipstick) panel - Urine

9119

74905

1.88

187.32

5.7

4.8

1.71

2.38

—

113

(3013115) Eosinophils [#/volume] in Blood

7467

58351

1.73

175.24

6.9

6.6

0.19

e9/l

0.25

6527

50660

(3018418) pH of Serum or Plasma

4993

35012

1.73

174.13

4.1

4.3

7.40

0.10

3527

25072

(3006315) Basophils [#/volume] in Blood

7298

56752

1.72

173.53

6.6

6.4

0.04

e9/l

0.54

6248

48460

(3001604) Monocytes [#/volume] in Blood

7263

56574

1.71

169.94

6.6

6.4

0.58

0.59

e9/l

5.21

6226

48295

(3019198) Lymphocytes [#/volume] in Blood

7364

57795

1.70

165.34

6.7

6.4

1.89

1.91

e9/l

0.25

6462

50582

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3762

24857

1.75

158.84

1.4

1.3

1.45

1.75

u/ml

0.68

950

6714

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2870

17530

1.84

158.22

2.6

2.7

22.76

22.04

2.16

2600

16261

(3013826) Glucose [Moles/volume] in Serum or Plasma

8095

65582

1.71

157.33

5.6

5.1

6.59

6.73

mmol/l

8.77

7751

62236

(3015736) pH of Urine

6212

47104

1.66

154.61

4.3

3.6

6.27

6.24

1.35

3240

25975

(3013650) Neutrophils [#/volume] in Blood by Automated count

7851

63388

1.68

151.38

9.5

9.8

4.11

4.16

e9/l

0.94

6825

54787

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

7425

59309

1.65

147.08

5.7

6.8

10.71

11.60

umol/l

9.97

7035

56538

(3009466) Valproate [Moles/volume] in Serum or Plasma

483

1349

3.69

146.68

6.6

4.9

387.60

353.24

umol/l

5.32

442

1149

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

3575

23775

1.71

144.68

1.8

1.7

22665316.20

32150921.63

pmol/l

0.56

2987

19670

(3035350) Ketones [Presence] in Urine by Test strip

7394

59176

1.64

143.65

4.9

4.1

2.00

4.05

estimate

0.72

1449

12600

(3021601) Nitrite [Presence] in Urine by Test strip

7323

58479

1.64

143.42

4.9

4.1

0.00

estimate

0.20

1426

12239

(3009261) Glucose [Presence] in Urine by Test strip

7424

59594

1.64

141.39

4.9

4.1

0.01

0.46

estimate

1.75

1373

11873

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3496

23236

1.71

141.09

2.8

3.1

2.45

2.46

mmol/l

7.87

3122

20822

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

11368

103851

2.56

136.87

21.6

17.1

22.36

24.78

mg/l

14.05

9862

86506

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

8426

70301

1.65

132.95

4.0

3.3

45.39

49.10

u/l

3.74

7887

65759

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4894

35919

1.61

131.48

2.9

2.7

56.23

63.43

u/l

2.41

4481

33249

(42870588) Differential panel, method unspecified - Blood

5145

38267

1.60

130.39

6.2

6.5

—

4.57

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1994

11487

1.88

129.38

2.0

1.7

1.50

1.47

1.44

1772

9955

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

5624

42770

1.59

129.31

4.8

3.9

117.29

66.30

ng/l

0.29

4053

30548

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

5412

40835

1.59

128.37

4.0

3.5

2.60

1.52

e6/l

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

11508

106182

2.71

127.50

25.6

20.3

139.65

mmol/l

0.05

11367

104161

(3023103) Potassium [Moles/volume] in Serum or Plasma

11519

106393

2.72

126.22

25.8

20.5

3.97

mmol/l

0.00

11369

104200

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

10900

98511

2.07

124.03

7.7

6.6

39.40

39.46

mmol/mol

0.32

10222

91944

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1429

7483

2.03

122.28

2.6

2.4

25.45

22.25

au/ml

0.54

133

781

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1338

6893

2.06

119.60

1.3

54.65

53.11

au/ml

0.08

467

(3006504) Eosinophils/Leukocytes in Blood

6540

52155

1.55

117.47

6.7

6.6

2.85

2.84

0.19

6097

48830

(3019069) Monocytes/Leukocytes in Blood

6553

52282

1.55

117.46

6.8

6.7

8.74

8.90

4.99

6102

48975

(3022096) Basophils/Leukocytes in Blood

6534

52158

1.55

116.36

6.8

6.7

0.68

0.35

6097

48797

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

11017

100376

2.09

115.99

6.3

5.3

5.95

5.96

mmol/l

0.18

10200

92054

(3007164) IgA [Mass/volume] in Serum or Plasma

3194

21636

1.65

115.48

1.5

2.29

2.46

g/l

5.75

1841

13179

(3024666) Lithium [Moles/volume] in Serum or Plasma

239

474

5.12

113.22

15.0

13.3

0.65

0.62

mmol/l

1.01

218

434

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1819

10612

1.84

111.94

2.3

367.47

379.76

nmol/l

1.91

1691

9831

(3002030) Lymphocytes/Leukocytes in Blood

6625

53380

1.53

110.50

6.8

6.6

27.75

27.39

1.90

6238

50508

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3494

24512

1.60

108.12

1.8

1.11

1.27

mg/l

1.91

2666

19173

(3018010) Neutrophils/Leukocytes in Blood

6506

52370

1.52

107.86

6.7

6.5

57.22

57.61

1.97

6187

49967

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3011

20447

1.63

106.25

1.4

1.3

28.72

34.39

iu/ml

1.40

886

6239

(3032080) INR in Blood by Coagulation assay

6527

52746

1.52

104.94

17.1

16.1

1.26

1.27

inr

0.51

5428

44143

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

659

2673

2.55

103.71

1.3

550.28

546.02

mg/l

0.03

621

2561

(3011397) Hemoglobin [Presence] in Urine by Test strip

3792

27346

1.56

103.11

4.7

3.9

0.52

0.35

0.28

303

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

4674

35374

1.52

101.53

3.4

3.2

1171.78

1476.58

ng/l

4.52

4005

30761

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

597

2356

2.61

99.35

1.2

1.3

3.81

3.77

mmol/l

0.42

561

2236

(3048689) Calprotectin [Mass/mass] in Stool

2198

13972

1.70

99.32

2.2

2.3

137.93

136.14

ug/g

0.08

1735

11054

(3018095) Leukocytes [#/volume] in Urine

5394

42262

1.50

98.13

4.8

4.1

94.59

102.96

e6/l

0.24

3912

29881

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2850

19484

1.61

96.27

2.1

1.9

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2784

19026

1.60

93.80

1.4

1.3

9.75

11.97

u/ml

0.97

1022

7308

(3002582) Erythrocytes [#/volume] in Urine

4833

37372

1.49

91.79

4.0

3.5

54.62

77.80

e6/l

1.07

3750

28585

(40768797) Stomach Pathology biopsy report

2377

15792

1.63

89.38

1.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2208

14435

1.65

88.43

2.0

1.8

—

(36304419) Bacteria [Presence] in Urine

4079

30650

1.50

88.29

3.7

3.3

0.16

116.29

estimate

0.69

144

(3020564) Creatinine [Moles/volume] in Serum or Plasma

11641

109912

2.56

88.20

28.0

22.4

78.00

77.93

umol/l

0.07

11548

108608

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

568

2337

2.50

86.52

1.3

1.4

9.92

37.60

e6/l

2.94

389

1732

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

571

2372

2.48

85.19

1.3

1.4

555.95

2936.92

e6/l

0.86

425

1877

(3030467) Casts [#/volume] in Urine by Automated count

4241

32344

1.48

84.24

3.8

3.4

0.31

0.44

e6/l

5.23

3175

23799

(3037522) Nuclear Ab [Titer] in Serum

2329

15600

1.61

84.04

1.4

553.75

516.02

titre

0.35

461

3438

(3023368) Bacteria identified in Blood by Culture

4165

31874

1.47

80.26

4.6

4.4

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

10814

99966

1.77

79.37

20.3

16.8

79.45

79.02

ml/min/173m2

1.39

10206

92828

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4666

36548

1.45

79.33

3.4

3.3

30.46

34.80

u/l

5.64

4341

34425

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

11543

109049

2.27

79.26

14.8

12.7

24.91

25.69

u/l

5.45

11272

105838

(3044889) 12 lead EKG panel

8528

74963

1.47

75.56

4.9

4.2

0.33

2791.08

0.73

155

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

11127

103972

1.87

75.55

6.7

6.0

2.62

2.68

mmol/l

10.28

10345

96568

(1002224) Polysomnography panel

869

4502

2.00

75.06

1.1

—

(3000850) Epithelial cells [#/volume] in Urine

3473

25920

1.48

74.86

2.9

2.8

5.47

5.73

e6/l

0.35

3182

23589

(3019150) Specific gravity of Urine by Refractometry

3463

25841

1.48

74.67

5.3

4.3

1.02

1.19

kg/l

1.04

2283

17392

(3029937) Albumin [Presence] in Urine by Test strip

4212

32710

1.44

73.34

5.3

4.3

0.01

0.00

estimate

0.54

1364

11280

(44816559) Phosphatidylethanol [Mass/volume] in Blood

821

4202

2.02

73.33

1.6

0.29

0.32

mg/l

0.82

346

1902

(36660697) Celiac disease serology panel - Serum

1428

8709

1.73

73.18

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

374

1358

2.81

73.10

2.4

2.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2015

13517

1.59

70.87

2.1

1.9

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

7256

62301

1.41

70.10

3.2

2.9

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1413

8750

1.70

68.16

1.5

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

259

796

3.30

67.71

1.1

279.14

290.86

mg/l

1.81

239

723

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

5345

43890

1.39

65.23

4.9

4.1

0.03

0.62

estimate

3.62

1164

10030

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

10939

102347

1.72

65.10

5.8

5.2

4.53

4.61

mmol/l

16.13

10205

95410

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2784

20403

1.47

63.96

3.5

3.1

1.17

1.29

e6/l

0.31

1518

10940

(3011288) Drugs identified in Urine by Screen method Nominal

493

2184

2.31

63.50

2.9

2.7

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

10874

101736

1.68

62.68

5.7

5.1

1.45

1.48

mmol/l

11.48

10072

94253

(3007461) Platelets [#/volume] in Blood

11692

111952

2.32

62.20

33.7

26.1

249.03

251.06

e9/l

2.93

11540

109646

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

11693

111978

2.31

61.97

34.1

26.5

40.13

40.51

2.11

11607

110711

(3035941) MCH [Entitic mass]

11692

111970

2.31

61.86

33.5

25.9

30.38

30.33

2.57

11610

110752

(3024731) MCV [Entitic mean volume] in Red Blood Cells

11692

111972

2.31

61.83

33.5

26.0

91.47

91.26

5.81

11609

110753

(3000963) Hemoglobin [Mass/volume] in Blood

11693

111994

2.31

61.67

33.9

26.2

133.53

134.06

g/l

3.80

11609

110815

(3026361) Erythrocytes [#/volume] in Blood

11692

111981

2.31

61.66

33.6

26.0

4.43

4.45

e12/l

4.24

11500

109295

(3010813) Leukocytes [#/volume] in Blood

11692

111992

2.30

61.46

33.7

26.1

6.78

6.76

e9/l

0.32

11512

109291

(3020630) Protein [Mass/volume] in Serum or Plasma

1549

10100

1.61

60.55

2.1

2.7

66.81

66.17

g/l

3.16

1404

9230

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

10459

97143

1.57

59.65

4.8

4.4

1.31

1.28

mmol/l

4.46

9564

89039

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2966

22289

1.44

58.88

4.6

4.0

253.77

443.81

ng/l

1.94

2288

17783

(3027945) Reticulocytes/Erythrocytes in Blood

1991

13836

1.53

58.66

2.4

2.5

1.72

1.80

3.14

1712

12343

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

287

1028

2.84

57.56

1.1

83.38

77.14

au/ml

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

213

646

3.34

56.92

1.1

4.20

9.39

nmol/l

0.60

125

(3026493) Urate [Moles/volume] in Serum or Plasma

3773

29748

1.39

56.39

2.7

2.8

336.41

342.68

umol/l

3.06

3261

26108

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1159

7185

1.68

55.04

1.9

1.7

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2148

15357

1.48

54.75

5.1

6.0

1.03

1.04

mmol/l

1.47

1986

14294

(3009508) Creatinine [Moles/volume] in Urine

4783

39318

1.36

54.58

3.5

7.30

7.27

mmol/l

0.17

3994

33092

(3033658) Prothrombin time (PT) actual/Normal

3640

28653

1.39

54.50

4.3

4.2

89.76

89.13

0.76

3547

28010

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1135

7056

1.67

53.24

3.2

3.5

4.45

pmol/l

0.00

993

6294

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1848

12931

1.51

52.08

8.5

7.2

—

(3001186) Copper [Moles/volume] in Serum or Plasma

122

265

4.64

52.02

1.1

1.3

16.31

16.84

umol/l

0.54

110

234

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

214

701

3.09

50.38

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

504

2492

2.07

49.20

2.3

2.1

—

(40761535) Cells panel - Urine sediment

1297

8507

1.59

48.78

4.1

3.5

—

1.00

—

(40758558) Short blood count panel - Blood

4138

33679

1.35

48.77

6.4

6.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

3115

24288

1.38

48.18

4.7

4.8

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

256

950

2.73

48.04

1.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1369

9135

1.56

47.72

3.5

3.9

86.05

91.14

ng/l

1.26

1188

7841

(3044640) Blood type and Crossmatch panel - Blood

4453

36727

1.34

47.69

2.5

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

901

5428

1.71

47.34

1.1

2.20

1.64

u/ml

—

(3023520) Reticulocytes [#/volume] in Blood

1568

10805

1.52

47.14

2.4

2.6

68.62

69.41

e9/l

0.38

1137

7984

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

223

779

2.90

46.89

1.2

1.1

36.94

41.08

mg/l

0.75

189

660

(3023410) Appearance of Cerebral spinal fluid

269

1037

2.63

46.84

1.4

1.5

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

122

289

4.25

46.66

1.3

1.2

107.77

128.85

nmol/l

0.90

209

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

6033

52057

1.32

46.60

2.9

—

estimate

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1307

8694

1.56

46.10

1.7

—

(3019225) pH of Specimen

1596

11116

1.50

45.47

4.6

4.3

7.37

7.36

1.11

1142

7910

(3014051) Protein [Presence] in Urine by Test strip

3869

31433

1.34

45.27

3.4

3.1

0.20

0.07

0.98

807

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

215

751

2.90

45.22

1.1

242.28

266.01

mg/l

0.98

192

666

(3003396) Base excess in Arterial blood by calculation

1885

13607

1.46

44.77

6.5

7.6

1.12

0.94

mmol/l

1.23

1597

11236

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1174

7671

1.59

44.67

3.7

5.21

5.15

kpa

2.04

1115

7328

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

729

4210

1.78

44.41

2.0

2.2

287.43

651.57

ug/l

4.78

682

3991

(3016879) Cocaine [Presence] in Urine

559

2976

1.92

44.19

2.3

2.0

—

(3019977) pH of Arterial blood

1895

13727

1.45

44.12

6.5

7.6

7.42

0.11

1060

7496

(3009343) pH of Capillary blood

1143

7455

1.59

43.79

3.7

7.42

0.12

948

6185

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1891

13727

1.45

43.47

6.5

7.6

5.13

5.08

kpa

1.60

1828

13226

(3027801) Oxygen [Partial pressure] in Arterial blood

1890

13723

1.45

43.38

6.5

7.6

11.75

12.36

kpa

6.76

1816

13216

(3021387) Prolactin [Units/volume] in Serum or Plasma

573

3095

1.89

43.34

1.8

1.7

288.78

300.00

mu/l

0.41

524

2813

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

619

3443

1.84

42.68

1.8

1.7

3.14

4.60

mg/l

4.01

521

2565

(3016502) Oxygen saturation in Arterial blood

1714

12271

1.46

42.28

6.8

7.9

95.45

95.52

0.19

1660

11858

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2441

18623

1.39

42.17

3.7

3.2

3.25

2.80

e6/l

1.03

1166

9135

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3465

27926

1.34

42.10

2.5

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1555

10934

1.48

42.02

2.7

2.5

33.98

43.47

u/l

1.32

1295

9256

(3000764) Benzodiazepines [Presence] in Urine

581

3189

1.86

41.79

2.3

2.0

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

740

4375

1.74

41.49

1.3

0.92

1.10

u/ml

0.14

364

(3023420) DNA double strand Ab [Units/volume] in Serum

779

4677

1.71

41.31

1.7

1.8

7.47

7.06

iu/ml

0.15

188

1094

(3000570) Elastase.pancreatic [Mass/mass] in Stool

636

3607

1.81

41.14

1.5

1.4

289.03

267.24

ug/g

1.93

386

2132

(3020961) Endomysium IgA Ab [Titer] in Serum

819

4993

1.69

41.03

1.2

1.1

311.54

197.37

titre

0.43

135

(3023183) Ammonium ion [Moles/volume] in Plasma

467

2401

1.98

40.88

2.3

2.7

30.02

33.85

umol/l

3.78

425

2153

(4027681) Cerebrospinal fluid IgG ratio and IgG index

173

567

3.08

40.77

1.2

0.56

0.59

ratio

0.31

332

(3027008) Opiates [Presence] in Urine

580

3209

1.85

40.66

2.3

1.9

—

(3028300) Cannabinoids [Presence] in Urine

581

3220

1.84

40.51

2.3

2.0

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

153

471

3.28

40.03

19.8

20.0

1371.16

3450.65

nmol/l

0.52

148

455

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2326

17741

1.39

39.96

2.0

2.1

29.40

29.69

1.69

2258

17249

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1003

6503

1.59

39.24

3.5

3.6

1.98

1.91

mmol/l

0.28

742

4823

(3005322) IgE [Units/volume] in Serum or Plasma

1060

6976

1.57

38.87

1.4

1.3

155.92

240.03

u/ml

3.99

991

6455

(3021589) Normoblasts [#/volume] in Blood

5608

48612

1.29

38.85

12.5

12.0

0.00

e9/l

0.40

4492

39513

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

176

4.86

38.47

2.4

1.9

17.31

16.34

umol/l

0.30

176

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

198

726

2.76

38.10

1.0

785.46

724.96

ng/l

0.86

137

507

(3017732) Neutrophils [#/volume] in Blood

1917

14254

1.41

38.07

3.0

3.3

4.40

4.57

e9/l

0.41

1573

12259

(3000494) Fungus identified in Specimen by Culture

1843

13618

1.42

37.93

1.6

1.5

—

(3026782) Osmolality of Urine

2798

22130

1.34

37.83

3.0

517.02

526.36

mosm/kgh2o

1.57

2437

19413

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

198

729

2.74

37.81

1.0

37.59

43.78

ng/l

1.03

139

517

(40768804) Tissue Pathology biopsy report

5205

44796

1.28

37.76

2.3

2.2

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

197

724

2.75

37.75

1.0

274.53

335.92

ng/l

3.72

143

521

(3027944) Amphetamines [Presence] in Urine

564

3170

1.82

37.55

2.3

2.0

—

(3003327) Ova and parasites identified in Stool by Light microscopy

657

3864

1.74

37.47

1.8

1.7

—

(3013512) EKG study

4610

39096

1.29

37.44

4.2

3.8

0.44

0.81

1.92

(3005719) IgG [Mass/volume] in Serum or Plasma

1258

8667

1.50

37.31

2.6

2.9

10.36

10.53

g/l

0.74

1161

8017

(3022145) Colonoscopy Study observation

1777

13087

1.42

37.19

1.3

1.4

—

(3012516) Albumin [Mass/volume] in Urine

4419

37304

1.29

37.10

3.5

50.66

47.59

mg/l

0.21

2755

23507

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

760

4671

1.67

36.83

2.2

2.4

2.78

2.91

g/l

3.53

685

4232

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1085

7292

1.54

36.12

1.3

1.2

110.33

143.99

u/ml

2.06

404

2703

(3022313) Gas panel - Capillary blood

822

5186

1.63

35.92

3.9

3.8

—

(3045414) Leukocytes [Presence] in Urine

1555

11265

1.44

35.53

2.3

2.1

0.02

0.01

estimate

0.17

287

2202

(3020682) Albumin/Creatinine [Ratio] in Urine

4474

37981

1.28

35.45

4.2

7.89

8.86

mg/mmol

0.62

2712

23371

(3014111) Lactate [Moles/volume] in Serum or Plasma

1474

10584

1.45

35.31

6.8

7.5

1.34

mmol/l

0.02

1447

10376

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1787

13286

1.40

35.25

2.5

2.7

6.35

8.69

umol/l

10.54

1490

11610

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1143

7812

1.51

35.13

2.9

2.2

12.83

12.75

nmol/l

0.11

1017

6978

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1568

11403

1.43

35.04

7.1

8.4

122.05

120.45

g/l

2.49

1534

11150

(3013139) Helicobacter pylori Ag [Presence] in Stool

1122

7680

1.51

34.19

1.2

1.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

788

4979

1.62

34.19

2.2

2.3

7.18

7.44

g/l

4.50

712

4536

(3023323) Follitropin [Units/volume] in Serum or Plasma

762

4778

1.63

34.10

1.4

26.43

29.39

iu/l

1.65

651

4105

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

785

4966

1.62

33.89

2.2

2.3

3.57

3.70

g/l

2.08

712

4526

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

587

3442

1.74

33.81

1.3

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

667

4053

1.68

33.72

4.0

3.9

25.06

24.90

mmol/l

0.78

616

3701

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

784

4975

1.62

33.41

2.2

2.3

4.20

4.22

g/l

0.23

709

4538

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

486

2716

1.82

32.96

2.2

1.8

41.49

42.55

nmol/l

0.45

470

2632

(3014765) Yersinia sp identified in Stool by Organism specific culture

513

2918

1.79

32.81

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

510

2897

1.79

32.77

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

828

5352

1.59

32.65

1.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

1778

13373

1.39

32.51

1.9

1.8

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

690

4273

1.65

32.41

2.2

2.4

0.58

0.88

g/l

1.58

594

3656

(3024869) Neuronal Ab [Presence] in Serum

194

4.30

32.41

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

513

2930

1.78

32.36

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1339

9640

1.44

31.40

2.6

2.4

5.27

7.18

ug/l

5.65

1128

8433

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

130

421

3.11

31.37

1.6

3.0

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

108

312

3.48

31.33

3.3

2.4

132.39

149.68

nmol/l

1.13

276

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

669

4165

1.64

30.76

1.6

26.65

17.51

u/ml

0.92

119

905

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

582

3499

1.70

30.60

1.3

31.00

38.45

u/ml

0.28

191

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

748

4807

1.59

30.19

1.8

2.0

39.19

39.44

u/l

0.13

666

4238

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

886

5924

1.53

30.02

1.6

1.5

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

997

6855

1.50

29.58

4.0

4.1

24.60

24.20

mmol/l

3.94

983

6784

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1038

7214

1.48

29.18

6.2

7.0

25.03

24.49

mmol/l

4.93

1006

6916

(3000991) Gas panel - Venous blood

1390

10203

1.41

29.12

8.1

8.8

—

(3020891) Body temperature

820

5437

1.55

28.84

4.9

4.6

36.91

°c

0.02

813

5392

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

675

4287

1.61

28.61

2.3

9.90

10.14

g/l

0.77

594

3795

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

540

3261

1.69

27.92

1.3

6.32

6.49

u/ml

0.04

498

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

557

3392

1.67

27.89

1.7

0.23

g/l

0.74

530

3217

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

888

6033

1.51

27.87

2.4

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

538

3262

1.68

27.39

1.3

10.65

3.98

u/ml

0.51

329

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

5134

45239

1.23

26.91

2.0

1.9

1.37

1.35

mmol/l

0.94

4308

37733

(3002032) Base excess in Venous blood by calculation

1522

11488

1.37

26.83

4.2

4.0

1.91

1.78

mmol/l

0.80

1382

10071

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

566

3497

1.65

26.80

1.7

1.19

g/l

0.21

543

3324

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

164

657

2.52

26.57

1.3

1.5

5.02

6.22

u/l

2.42

141

560

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

578

3599

1.64

26.54

2.2

2.3

0.01

0.04

g/l

2.54

523

3223

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

562

3477

1.65

26.47

2.3

0.00

g/l

0.24

491

3026

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1556

11812

1.36

26.43

4.1

3.9

5.87

5.81

kpa

1.59

1518

11540

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

375

2078

1.83

26.18

2.3

1.9

189.07

199.35

pmol/l

1.04

357

1947

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

146

559

2.63

25.96

1.1

1.03

1.13

u/l

1.87

237

(3012544) pH of Venous blood

1567

11975

1.35

25.43

4.1

4.0

7.38

0.52

831

6913

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

526

3235

1.65

25.36

2.3

2.4

0.00

g/l

-0.00

489

3017

(3025941) Bacteria identified in Stool by Culture

842

5799

1.49

24.66

1.3

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1767

13839

1.32

24.18

3.4

4.5

237.76

245.95

u/l

1.46

1646

13108

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

9124

85905

1.25

23.80

25.7

21.1

13.66

13.70

1.57

9045

84808

(46235355) HIV 1 and 2 tests - Meaningful Use set

2162

17451

1.29

23.62

2.0

1.9

—

(3033942) Copper [Moles/time] in 24 hour Urine

8.59

23.62

1.1

0.35

0.47

umol/24h

0.20

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

426

2535

1.71

23.28

1.3

42.47

44.93

u/ml

0.10

254

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

438

2629

1.69

23.19

1.1

2.82

8.52

eliau/ml

3.46

310

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1466

11257

1.34

22.89

2.2

2.3

0.22

0.21

g/l

5.89

1367

10502

(3018405) Lactate [Moles/volume] in Arterial blood

581

3754

1.58

22.87

3.8

4.0

1.34

1.40

mmol/l

0.75

576

3689

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1713

13463

1.32

22.75

5.6

5.1

33.11

32.84

0.44

1149

8896

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

382

2227

1.74

22.49

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

382

2227

1.74

22.49

1.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

435

2632

1.68

22.35

1.5

1.4

10.54

11.24

u/l

0.46

345

2120

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

634

4204

1.54

22.24

1.2

1.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

217

1060

2.07

22.04

1.4

1.5

—

(3042936) Bacteria identified in Isolate by Culture

2025

16343

1.29

21.97

2.0

2.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

184

847

2.19

21.79

1.3

1.96

2.14

mmol/l

1.59

171

795

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3634

31393

1.23

21.64

6.0

5.8

2.33

3.34

ug/l

3.31

3264

28355

(3051339) Copper [Moles/volume] in Blood

6.89

21.60

1.2

1.1

15.74

17.14

umol/l

1.36

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

123

476

2.60

21.49

1.3

1.7

30.04

29.69

umol/l

0.15

114

451

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

437

2676

1.66

21.45

1.2

1.1

3.34

3.92

0.68

314

(3041096) Erythrocytes [Presence] in Urine by Automated

3596

31080

1.22

21.21

4.1

3.5

0.09

0.36

estimate

2.22

1174

9716

(3024354) Oxygen [Partial pressure] in Venous blood

1293

9858

1.35

21.07

3.5

3.3

4.55

4.49

kpa

0.53

1256

9606

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

298

1649

1.83

20.97

1.3

0.59

3.27

nmol/l

1.21

289

1593

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

470

2955

1.61

20.77

1.3

11.30

15.69

u/ml

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

303

1691

1.81

20.74

1.3

0.40

0.17

nmol/l

0.86

100

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

448

2789

1.63

20.61

1.3

2.28

4.84

u/ml

0.88

194

(3009445) Proteinase 3 Ab [Units/volume] in Serum

718

4964

1.47

20.59

1.3

1.6

20.31

14.54

iu/ml

0.28

132

(3015235) Bicarbonate [Moles/volume] in Capillary blood

614

4116

1.52

20.47

2.6

3.0

25.08

24.80

mmol/l

1.14

606

4045

(3004716) Salmonella sp identified in Stool by Organism specific culture

699

4818

1.48

20.35

1.3

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

267

1442

1.87

20.31

1.3

0.19

0.20

nmol/l

0.57

212

1137

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

169

774

2.20

20.30

1.8

2.2

18.59

17.85

nmol/l

0.56

164

724

(3028026) IgM [Mass/volume] in Serum or Plasma

936

6815

1.40

20.26

1.9

1.33

g/l

0.02

852

6249

(4198724) Urine methamphetamine measurement

354

2.81

20.20

2.1

3.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2957

25156

1.23

20.11

5.0

4.7

22.16

22.10

0.07

1424

12903

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

967

7097

1.39

19.97

8.0

9.3

24.43

24.29

mmol/l

0.63

936

6956

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

133

560

2.39

19.48

1.1

—

(3049717) Cytology report of Urine Cyto stain

627

4277

1.49

19.22

2.5

2.8

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

207

1048

1.99

19.11

1.8

1.7

420.51

358.57

mu/l

0.74

172

826

(4024509) Urine culture

766

5443

1.43

19.00

2.2

2.0

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

168

792

2.14

18.80

1.6

1.4

1.05

1.20

promille

0.65

133

629

(3024891) Influenza virus A+B Ag [Presence] in Specimen

426

2683

1.61

18.72

1.2

1.1

—

(3045424) Erythrocytes [Presence] in Urine

794

5698

1.42

18.65

2.3

2.2

0.06

0.16

estimate

0.30

218

1717

(3020779) Urea [Moles/volume] in Serum or Plasma

1356

10605

1.31

18.41

6.3

7.4

9.70

10.17

mmol/l

1.61

1280

10156

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1216

9367

1.33

18.37

3.0

174.44

200.95

ng/l

1.89

1125

8621

(3042517) Benzodiazepines panel - Urine

5.08

18.31

2.4

2.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

264

1473

1.81

18.14

1.6

1.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

122

513

2.39

17.96

1.5

1.6

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

122

514

2.39

17.88

1.1

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

9026

85680

1.21

17.68

28.9

22.0

331.64

331.77

g/l

0.74

8987

85200

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1233

9584

1.32

17.45

2.7

2.5

0.43

0.44

e6/l

0.08

1172

9199

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

761

5489

1.41

17.36

2.2

2.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1472

11740

1.29

17.18

1.6

—

(3008898) HLA-B27 [Presence]

501

3376

1.50

16.33

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

447

2948

1.54

16.12

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

594

4177

1.44

15.60

2.0

1.9

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

636

4540

1.42

15.39

2.1

2.0

—

(3035637) Corticotropin [Mass/volume] in Plasma

255

1483

1.73

15.28

1.6

1.5

32.70

28.93

ng/l

0.28

255

1478

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

105

445

2.37

15.26

1.1

1400.44

293.89

ng/l

0.49

118

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

632

4513

1.42

15.26

2.1

2.0

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

594

4197

1.44

15.21

2.7

3.3

39.52

47.97

mg/l

0.76

515

3559

(3034860) Kappa light chains.free [Mass/volume] in Serum

592

4198

1.43

14.86

2.7

3.3

48.55

65.03

mg/l

0.57

513

3560

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

118

534

2.22

14.74

2.5

2.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

763

5667

1.37

14.60

1.6

1.7

1.51

1.56

g/l

0.89

647

4892

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

246

1443

1.72

14.32

2.1

20.64

25.46

mg/l

1.00

524

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

480

3295

1.48

14.31

1.5

18.08

13.71

iu/ml

—

(3003129) Base excess in Capillary blood by calculation

237

1379

1.73

14.21

2.2

2.3

0.75

0.49

mmol/l

0.52

231

1325

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1175

9333

1.29

14.04

2.4

2.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1084

8522

1.30

14.02

2.3

2.0

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

256

1529

1.69

13.96

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

518

3646

1.44

13.56

1.3

—

(3022621) pH of Urine by Test strip

1142

9078

1.28

13.55

3.1

2.7

6.10

6.07

0.52

741

6171

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

259

1577

1.66

13.15

1.2

1.1

39461.14

1642.99

iu/ml

0.47

340

(3052851) Hemolysis interference index of Serum or Plasma

460

3190

1.46

13.04

3.4

3.3

2.00

2.03

index

0.03

219

1631

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

266

2.64

12.87

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

261

2.65

12.80

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

261

2.65

12.80

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

418

2862

1.48

12.66

2.1

2.3

131.59

128.17

g/l

2.04

313

2178

(3024522) Salmonella sp identified in Specimen by Organism specific culture

247

1504

1.66

12.56

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

246

1497

1.66

12.54

1.4

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

269

1675

1.62

12.52

1.1

13.37

15.43

au/ml

0.17

370

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

330

2.43

12.43

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

373

2.34

12.41

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

141

732

1.94

12.29

1.3

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

178

2.99

12.27

2.2

2.0

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

981

7745

1.29

12.26

7.5

7.9

24.99

24.82

mmol/l

0.73

972

7697

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

446

3115

1.45

12.21

1.8

2.0

41.03

5.81

iu/l

0.73

165

1248

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

106

503

2.12

11.85

3.0

1.9

158.57

129.57

umol/l

0.37

254

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

561

4113

1.38

11.66

2.8

2.7

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

138

725

1.91

11.64

1.3

1.2

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

1125

9097

1.26

11.56

2.6

2.7

65.42

64.69

ml/min/173m2

0.27

488

3875

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

263

1664

1.59

11.50

1.2

11.00

8.74

u/ml

—

(3011985) Renin [Units/volume] in Plasma

266

1690

1.59

11.43

1.5

1.4

78.85

61.15

mu/l

0.41

243

1518

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2150

18593

1.19

11.39

3.5

3.4

0.71

0.79

ug/l

2.34

1488

12659

(4034850) Laboratory test

457

3251

1.42

11.34

12.4

10.6

—

(3037121) Protein [Mass/volume] in Urine

535

3920

1.38

11.18

2.9

3.2

325.70

455.02

mg/l

1.42

204

1691

(3000475) Leukocytes [#/volume] in Synovial fluid

418

2936

1.44

11.13

1.6

12678.97

14029.57

e6/l

0.30

301

2036

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

249

1570

1.60

11.06

1.4

1.3

341.76

325.76

pmol/l

0.18

221

1327

(3047181) Lactate [Moles/volume] in Blood

478

3445

1.40

11.02

4.7

5.9

1.26

1.33

mmol/l

0.66

431

3065

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

242

1517

1.61

11.02

1.4

0.32

0.37

nmol/l

0.58

192

1127

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

515

3763

1.38

10.95

2.7

3.2

3.07

4.71

ratio

0.56

301

2193

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

176

1018

1.74

10.89

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1789

15281

1.20

10.83

1.7

1.6

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

187

2.79

10.70

2.2

1.9

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1397

11669

1.22

10.64

1.6

—

6.32

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

125

657

1.91

10.57

1.3

1.5

22.66

23.15

umol/l

0.06

113

607

(3004616) Nuclear Ab [Presence] in Serum

235

1480

1.60

10.52

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

229

1439

1.60

10.35

1.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

298

1999

1.50

10.07

1.2

1.1

2.79

1.86

u/ml

0.68

160

1057

(3024928) Oxygen saturation in Venous blood

412

2941

1.42

10.07

3.0

3.2

62.16

61.23

0.36

391

2855

(3003181) Sodium [Moles/volume] in Urine

332

2277

1.47

10.06

1.3

1.4

62.33

62.21

mmol/l

0.02

263

1816

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

153

871

1.77

10.05

1.2

1.1

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

134

733

1.84

10.04

1.3

1.4

13.42

12.62

umol/l

0.54

124

683

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

148

835

1.78

10.02

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

228

1446

1.59

9.93

1.4

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

103

518

2.00

9.93

1.2

59.20

64.87

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

157

904

1.75

9.92

1.2

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

144

809

1.79

9.90

1.2

1.3

1.45

1.61

u/ml

0.11

471

(3005988) Vibrio sp identified in Specimen by Organism specific culture

228

1449

1.58

9.85

1.4

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

152

869

1.76

9.85

1.2

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

211

1317

1.61

9.83

1.1

3.10

3.68

eliau/ml

0.23

577

(3014271) Vancomycin [Susceptibility]

103

520

1.99

9.83

3.1

2.9

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

154

885

1.75

9.80

1.2

1.1

—

(3044927) Protein electrophoresis panel - Urine

193

1180

1.65

9.77

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

282

1891

1.50

9.57

1.6

0.65

0.78

g/l

1.74

228

1456

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

148

851

1.75

9.42

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

218

2.53

9.40

1.1

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1008

8243

1.24

9.37

1.8

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

109

572

1.91

9.32

1.1

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

243

2.43

9.31

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

428

3120

1.39

9.28

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

180

1097

1.65

9.25

1.1

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

742

5863

1.28

9.23

4.1

49.86

47.13

2.42

733

5783

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

296

2023

1.47

9.17

1.2

1.3

33.51

34.30

u/l

0.03

247

1746

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

427

2.04

9.01

1.3

1.2

—

(3018333) Ribosomal P Ab [Presence] in Serum

142

818

1.74

9.00

1.2

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

418

3052

1.38

8.99

1.9

2.1

11.40

12.08

mg/l

0.93

387

2837

(3017315) Amylase [Enzymatic activity/volume] in Urine

107

567

1.90

8.91

1.2

186.48

282.48

u/l

1.60

519

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

219

1418

1.55

8.78

1.1

1.92

2.85

0.84

197

(40761536) Microorganisms panel - Urine sediment

1062

8794

1.23

8.78

4.7

4.2

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

198

1253

1.59

8.77

1.2

50.60

38.07

u/ml

—

(3002079) Sodium [Moles/time] in 24 hour Urine

494

1.95

8.73

1.3

158.07

159.06

mmol/24h

0.04

494

(3040151) Glucose [Moles/volume] in Capillary blood

206

1321

1.57

8.63

8.9

11.0

7.73

7.32

mmol/l

0.52

163

1107

(43055514) Macroprolactin [Presence] in Serum or Plasma

198

2.53

8.60

1.3

1.5

—

(4146454) Self-monitoring of blood glucose

194

1228

1.59

8.59

2.7

2.6

—

(3036489) Thrombin time

540

4131

1.32

8.58

1.7

2.1

21.12

21.07

0.05

482

3669

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

276

1887

1.47

8.56

1.3

1.4

8.64

14.35

u/ml

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

418

3088

1.37

8.39

2.6

2.2

6166.41

4964.68

u/l

0.27

143

1214

(3001019) Free T4 and TSH panel - Serum or Plasma

594

4625

1.30

8.30

1.9

1.7

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

373

2.07

8.30

1.5

1.4

84.86

300.68

nmol/24h

1.65

373

(3039162) Centromere protein B Ab [Units/volume] in Serum

221

1453

1.53

8.30

1.3

49.65

63.76

u/ml

0.31

103

(3010838) Calcium [Moles/time] in 24 hour Urine

297

2077

1.44

8.21

2.0

1.9

4.99

4.92

mmol/24h

0.07

267

1837

(3003888) Timothy IgE Ab [Units/volume] in Serum

254

1728

1.48

8.11

1.1

5.53

4.80

u/ml

0.26

110

897

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

837

6815

1.25

8.10

8.1

9.8

16.12

15.91

1.46

807

6591

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

370

2.06

8.09

1.2

0.30

0.31

g/l

0.11

297

(37208534) Antinuclear antibody arbitrary concentration in serum

338

2.11

8.02

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

104

567

1.84

7.98

1.4

1.3

157.31

177.55

pmol/l

0.49

104

567

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

441

1.96

7.94

2.3

2.4

49.60

53.67

umol/l

0.63

387

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

491

1.90

7.88

1.2

1.1

—

0.12

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1114

9370

1.21

7.86

3.8

4.0

1.23

mmol/l

0.14

936

8070

(3027135) IgG subclass 1 [Mass/volume] in Serum

183

1169

1.57

7.84

1.5

1.4

6.24

6.71

g/l

1.39

144

835

(3024139) IgG subclass 3 [Mass/volume] in Serum

183

1169

1.57

7.84

1.5

1.4

0.37

0.41

g/l

1.23

144

833

(3028192) IgG subclass 2 [Mass/volume] in Serum

183

1170

1.57

7.81

1.5

1.4

2.87

2.90

g/l

0.08

143

837

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

349

2.07

7.77

1.2

105.62

111.65

1.33

307

(3034274) Bile acid [Moles/volume] in Serum --fasting

172

1090

1.59

7.63

1.6

2.1

7.05

8.15

umol/l

0.31

112

801

(3004119) Hemoglobin [Mass/volume] in Venous blood

886

7308

1.23

7.61

3.4

128.94

128.47

g/l

0.26

866

7103

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.71

7.61

1.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.97

7.60

1.3

1.5

498.00

555.15

nmol/l

0.16

(3021879) Hepatitis B virus core Ab [Presence] in Serum

949

7889

1.22

7.56

1.4

—

(3010421) pH of Blood

479

3677

1.32

7.47

3.5

3.7

7.41

0.58

471

3636

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

606

4798

1.28

7.47

2.0

1.9

1.73

2.22

ug/l

0.65

508

4247

(3008401) Mugwort IgE Ab [Units/volume] in Serum

243

1668

1.47

7.45

1.1

0.92

1.06

u/ml

0.17

721

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

263

2.21

7.43

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

383

1.99

7.40

1.4

1.5

14.46

16.00

pmol/l

1.53

316

(3026389) Candida sp identified in Specimen by Organism specific culture

246

1695

1.46

7.40

1.5

1.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

200

1327

1.52

7.26

1.1

4.80

3.73

u/ml

0.32

573

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

333

2.05

7.18

1.3

—

(3028626) Oxygen [Partial pressure] in Capillary blood

387

2900

1.35

7.14

3.3

3.2

8.35

8.11

kpa

2.13

377

2830

(3002179) Metamyelocytes/Leukocytes in Blood

1171

9983

1.19

7.14

3.9

4.3

0.66

0.73

0.47

347

3122

(3007566) Smooth muscle Ab [Titer] in Serum

419

3179

1.33

7.11

1.2

101.33

135.21

titre

0.52

303

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

223

1530

1.47

6.89

1.1

1.48

1.52

g/l

0.98

205

1391

(4062490) Immunoglobulin typing, IgG

175

1142

1.54

6.88

1.5

1.4

—

(3017181) Myelocytes/Leukocytes in Blood

1222

10491

1.18

6.87

4.1

4.5

0.91

0.95

0.20

349

3287

(3021440) Promyelocytes/Leukocytes in Blood

1172

10037

1.19

6.78

4.1

4.5

0.17

0.11

0.91

302

2839

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

171

1114

1.54

6.78

1.6

1.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

114

672

1.70

6.78

1.6

1.4

—

(3025159) Blasts/Leukocytes in Blood

1182

10132

1.18

6.77

4.3

4.7

0.09

0.34

2.69

297

2708

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

210

1431

1.48

6.73

1.3

30.39

29.70

u/l

0.09

157

1176

(3025018) Bordetella pertussis Ab [Titer] in Serum

117

698

1.68

6.66

1.3

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

207

1410

1.48

6.65

1.1

4.05

3.40

u/ml

0.20

686

(3010726) Horse dander IgE Ab [Units/volume] in Serum

229

1593

1.45

6.60

1.1

1.55

1.32

u/ml

0.23

112

789

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

6.16

6.45

1.4

1.8

117.50

209.39

nmol/l

—

(3008295) Osmolality of Serum or Plasma

193

1306

1.49

6.42

1.4

280.23

277.31

mosm/kgh2o

0.92

146

979

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1868

16653

1.14

6.38

1.5

—

(3021901) Oxygen saturation in Capillary blood

329

2450

1.35

6.38

2.8

3.1

90.66

89.68

1.88

318

2383

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

284

2068

1.38

6.34

2.1

1.8

—

(3019230) Fractional oxyhemoglobin in Venous blood

335

2506

1.35

6.31

3.0

2.9

62.76

61.49

0.50

335

2499

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

400

1.88

6.26

1.3

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

293

2155

1.37

6.16

1.2

1.3

160.31

316.48

titre

1.74

169

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

104

2.79

6.13

1.0

—

(3034770) Mitochondria Ab [Titer] in Serum

409

3163

1.30

6.11

1.2

530.00

884.27

titre

—

103

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

149

966

1.55

6.09

1.2

106.44

109.96

pmol/l

0.37

149

966

(40760888) Immunoglobulin light chains.free panel - Serum

367

2798

1.32

6.08

2.4

3.5

—

856.11

—

(21494755) Public health laboratory ask at order entry panel

678

8204

0.82

6.08

1.4

—

(3028717) Thiamine [Mass/volume] in Blood

158

2.41

6.00

1.1

1.2

59.58

64.32

ug/l

0.80

158

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1309

11433

1.16

5.94

3.8

3.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

167

1117

1.50

5.92

4.1

3.6

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

122

762

1.61

5.86

1.1

10.00

9.06

iu/ml

0.08

199

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

251

1816

1.39

5.86

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

6.37

5.85

1.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

425

3327

1.29

5.81

1.4

1.3

—

(1616796) Gas panel - Central venous blood

339

2576

1.33

5.77

3.5

3.8

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

102

2.75

5.77

1.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

190

1314

1.45

5.71

1.1

1.2

—

(40768443) Skin Pathology biopsy report

648

5337

1.23

5.71

1.2

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

6.09

5.68

1.6

1.9

130.78

246.47

nmol/l

—

(3023419) Bacteria identified in Sputum by Culture

214

1516

1.42

5.66

3.1

2.6

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

235

1693

1.40

5.64

1.3

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

160

1074

1.50

5.60

1.3

1.4

112134.03

161303.06

e6/l

0.47

713

(1761482) Bacteria [#/volume] in Urine by Culture

198

2789

0.71

5.59

5.0

4.3

—

(3038026) Centromere Ab [Units/volume] in Serum

141

922

1.54

5.58

1.3

1.2

101.51

52.79

u/ml

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

3.28

5.57

1.0

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

551

1.69

5.51

1.7

1.6

5.34

5.33

nmol/l

0.00

450

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

333

2545

1.32

5.47

1.3

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

341

2617

1.31

5.44

1.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

225

1623

1.39

5.38

1.2

1.92

3.88

u/ml

3.06

595

(3019420) Tryptase [Mass/volume] in Serum or Plasma

601

1.65

5.37

1.1

1.6

5.40

8.59

ug/l

4.10

543

(3012501) Base excess in Blood by calculation

309

2345

1.33

5.34

3.8

4.1

2.51

2.56

mmol/l

0.12

212

1602

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

355

2748

1.30

5.32

1.4

1.7

—

(3013290) Carbon dioxide [Partial pressure] in Blood

309

2347

1.32

5.31

3.8

4.1

5.09

4.99

kpa

1.94

301

2301

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

3.28

5.29

1.1

1.6

42.25

35.50

0.22

(3027315) Oxygen [Partial pressure] in Blood

310

2364

1.32

5.19

3.8

4.1

8.78

8.60

kpa

1.09

302

2318

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

174

1209

1.45

5.15

1.1

1.2

—

28.72

u/ml

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

109

2.57

5.11

1.1

2.2

—

(3002256) Pathology report gross observation

1709

15361

1.13

5.10

1.3

—

(3037756) Immunofixation for Serum or Plasma

332

2565

1.30

5.07

1.4

1.7

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

3.40

5.01

1.0

—

(3037577) Monocytes/Leukocytes in Cerebral spinal fluid

3.40

5.01

1.1

1.7

7.27

15.30

1.13

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

218

2.07

5.01

1.2

1.3

0.57

100.78

mg/l

1.69

158

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

279

2109

1.33

4.99

2.3

1.8

0.91

0.85

nmol/l

0.67

226

1797

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

173

1209

1.44

4.98

1.1

1.0

0.09

0.29

u/ml

1.51

395

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

218

1587

1.38

4.97

1.2

3.57

4.18

u/ml

0.45

730

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

366

1.81

4.96

2.7

3.0

25.54

28.22

umol/l

0.80

279

(40757494) Bilirubin.total [Moles/volume] in Blood

568

1.64

4.96

2.3

2.2

15.41

32.56

umol/l

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

456

1.72

4.90

2.1

2.0

56.94

63.03

ug/l

0.44

443

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

288

2195

1.32

4.87

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

382

3023

1.27

4.86

1.5

1.6

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

118

2.46

4.86

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

533

1.66

4.85

1.1

1722.93

1510.29

miu/ml

0.94

533

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.99

4.81

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

107

2.53

4.78

1.0

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

293

2246

1.31

4.77

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

167

1170

1.43

4.76

1.5

1.7

—

(3003577) Lead [Moles/volume] in Blood

2.88

4.75

1.0

1.3

0.08

0.19

umol/l

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

102

645

1.59

4.74

1.2

1.1

—

(3003694) ABO and Rh group [Type] in Blood

3242

30276

1.10

4.71

1.4

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

562

1.62

4.67

1.2

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

120

791

1.52

4.65

1.7

1.8

106.19

105.70

ng/l

0.02

120

791

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

240

1796

1.34

4.63

1.6

1.7

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

134

2.32

4.57

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

111

723

1.54

4.56

2.3

2.4

494.01

515.61

e6/l

0.21

574

(3027923) C peptide [Moles/volume] in Serum or Plasma

613

1.59

4.54

1.6

1.4

1.07

1.26

nmol/l

0.95

457

(3008757) Leukocyte morphology finding [Identifier] in Blood

166

1174

1.42

4.52

2.8

4.0

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

491

1.65

4.49

1.5

1355524.00

1476530.24

iu/ml

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

232

3067

0.75

4.45

1.1

0.61

0.62

ratio

0.07

421

(3016038) Potassium [Moles/volume] in Urine

122

818

1.50

4.39

1.2

31.70

34.66

mmol/l

0.85

106

707

(3017817) Protein [Mass] in Urine collected for unspecified duration

141

974

1.45

4.37

2.6

929.76

1001.23

0.23

141

967

(44813793) Dust mix specific IgE antibody measurement

113

747

1.52

4.35

1.1

—

(44790048) Parainfluenza type 2 nucleic acid detection

195

1428

1.37

4.34

1.3

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

195

1428

1.37

4.34

1.3

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

195

1428

1.37

4.34

1.3

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

195

1428

1.37

4.34

1.3

1.5

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.88

4.32

1.1

—

(3039000) Anion gap in Blood by calculation

304

2380

1.28

4.26

5.8

6.9

11.03

11.29

mmol/l

0.61

273

2147

(3020874) Milk IgE Ab [Units/volume] in Serum

568

1.59

4.26

1.1

7.65

1.51

u/ml

0.40

182

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

436

3561

1.23

4.25

1.5

6.53

8.99

iu/ml

0.12

680

(3018572) Chloride [Moles/volume] in Blood

304

2381

1.28

4.25

5.8

6.9

104.88

104.99

mmol/l

0.15

273

2149

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

180

1308

1.38

4.22

1.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

138

958

1.45

4.19

1.5

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

138

958

1.45

4.19

1.5

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

138

958

1.45

4.19

1.5

1.6

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

3.26

4.18

1.5

1.4

41.13

27.48

nmol/l

0.36

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

556

1.59

4.16

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

556

1.59

4.16

1.4

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

101

659

1.54

4.15

1.1

15.45

19.00

u/ml

0.72

259

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

153

1085

1.42

4.14

1.6

1.7

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

621

5264

1.19

4.14

4.0

3.5

25.35

25.15

mmol/l

0.81

601

5098

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

254

1952

1.31

4.12

1.4

152.89

154.60

au/ml

0.06

565

(3028679) Herpes simplex virus Ab [Presence] in Serum

535

1.59

4.09

1.2

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

366

2949

1.25

4.06

1.5

1.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

279

2176

1.29

4.05

1.5

1.4

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

121

826

1.47

4.02

1.4

1.3

278.75

555.57

titre

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

118

802

1.48

4.01

1.4

1.3

81.43

69.12

titre

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

491

1.61

4.01

1.6

1.8

1.95

1.96

umol/l

0.03

452

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.67

3.98

1.1

9.00

13.36

u/l

0.58

(3015076) Soybean IgE Ab [Units/volume] in Serum

493

1.61

3.95

1.0

0.57

2.05

u/ml

0.57

125

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

486

1.61

3.93

1.4

1.3

4.59

4.33

umol/l

0.24

432

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

471

1.62

3.91

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

129

899

1.44

3.87

1.3

9.09

8.85

mmol/l

0.24

120

850

(3003740) Influenza virus B Ag [Presence] in Specimen

223

1700

1.32

3.86

1.2

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

271

3438

0.78

3.85

1.3

1.2

0.90

0.89

g/l

0.33

271

3428

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

242

1.86

3.81

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

545

1.56

3.81

1.0

1.1

3.02

1.39

u/ml

0.29

133

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

408

3360

1.22

3.72

1.8

2.3

94.67

92.50

1.18

396

3239

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

115

2.26

3.70

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

384

3146

1.23

3.69

2.0

2.5

192.53

197.49

0.48

367

2999

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

148

1069

1.39

3.65

2.7

2.9

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

109

745

1.47

3.64

2.5

233.99

227.40

e6/l

0.14

629

(3002523) Influenza virus A Ag [Presence] in Specimen

221

1698

1.31

3.64

1.2

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

291

1.76

3.59

1.0

12.86

10.49

u/ml

0.21

190

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

306

1.74

3.58

1.9

1.6

0.48

0.37

ug/l

0.80

212

(3016650) Hepatitis A virus Ab [Presence] in Serum

228

1764

1.30

3.57

1.1

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

183

1373

1.34

3.57

1.5

1.6

52.99

58.67

0.99

104

864

(3008116) Ketones [Moles/volume] in Urine by Test strip

248

1.82

3.55

1.5

0.13

0.32

mmol/l

—

(3025130) Human papilloma virus identified in Specimen

202

1539

1.32

3.54

1.7

1.8

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

144

2.09

3.51

1.0

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

473

3976

1.20

3.51

2.8

3.1

0.35

iu/ml

0.02

259

2206

(3006270) Folate [Moles/volume] in Blood

126

892

1.42

3.51

1.1

1.2

340.29

351.91

nmol/l

0.28

113

742

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.33

3.49

1.3

1.2

—

(40767503) Oxygen content in Capillary blood by calculation

303

2449

1.24

3.34

2.7

16.88

16.22

3.44

297

2400

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

225

1758

1.29

3.30

1.1

1.2

1.68

0.81

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

309

2507

1.24

3.30

2.1

2.4

97.75

103.65

ug/min

0.08

173

1458

(3032057) Clostridioides difficile [Presence] in Stool

240

1.79

3.29

1.8

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

112

787

1.43

3.28

1.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

365

3016

1.22

3.27

1.5

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

203

1568

1.30

3.26

1.8

2.1

32.37

32.53

0.22

203

1556

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

122

2.13

3.25

1.2

1.1

—

(3007463) Buprenorphine [Presence] in Urine

3.80

3.18

4.4

6.9

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

399

3337

1.20

3.17

1.9

2.6

3.56

3.61

g/l

0.28

379

3186

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

144

2.02

3.14

1.0

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

129

937

1.38

3.14

1.5

24.60

24.09

u/ml

0.03

173

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

244

1.77

3.13

1.1

1.2

629.59

309.54

pmol/l

0.34

178

(3010370) Gastrin [Moles/volume] in Serum or Plasma

179

1.90

3.13

1.6

2.0

24.53

51.64

pmol/l

2.36

151

(21494890) Protein electrophoresis panel - 24 hour Urine

161

1212

1.33

3.12

1.9

2.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.67

3.08

1.0

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

446

1.55

3.06

1.1

2.13

6.55

u/ml

—

(3017354) Segmented neutrophils/Leukocytes in Blood

171

1303

1.32

3.05

2.8

3.6

61.54

57.26

2.07

145

1125

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.22

3.05

1.1

1.2

1.66

1.64

umol/24h

0.03

(3022640) Eosinophils/Leukocytes in Cerebral spinal fluid

3.17

3.05

1.1

1.5

5.86

1.18

—

(3000060) B lymphocytes [#/volume] in Blood

285

1.69

3.00

2.4

1.9

0.23

0.73

e9/l

0.82

125

(3035320) C reactive protein [Mass/volume] in Body fluid

122

886

1.38

2.99

4.3

2.7

28.42

29.05

mg/l

0.06

654

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

112

803

1.40

2.96

1.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

107

2.15

2.95

2.0

1.7

39.04

46.07

umol/l

0.82

107

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

150

1129

1.33

2.93

1.4

1.3

1.50

1.48

nmol/l

0.07

139

1013

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

228

1.76

2.89

1.2

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

135

2.00

2.89

1.1

1.4

45.75

53.37

0.30

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

4.09

2.88

2.0

179.00

272.20

ug/l

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

116

842

1.38

2.87

1.1

—

(3035060) Mercury [Moles/volume] in Blood

5.39

2.86

1.9

2.2

13.91

11.11

nmol/l

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

527

1.48

2.85

1.2

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

157

1.91

2.83

1.2

171.95

690.71

ng/l

0.46

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

169

1301

1.30

2.83

1.2

62.04

62.88

u/l

0.04

147

1133

(3020491) Glucose [Moles/volume] in Blood

107

768

1.40

2.83

1.9

6.74

6.80

mmol/l

0.10

542

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

676

1.42

2.83

1.1

18.80

25.92

u/l

1.35

604

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

685

1.42

2.82

1.1

69.46

84.37

u/l

2.34

612

(3013336) Amino acids [Identifier] in Serum or Plasma

4.45

2.79

1.5

3.9

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

309

2558

1.21

2.78

3.8

3.3

0.86

0.82

nmol/l

0.45

257

2060

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

315

1.62

2.77

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

482

1.50

2.76

1.5

1.9

40.07

40.10

g/l

0.01

482

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

138

1.96

2.74

1.0

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

300

2482

1.21

2.72

1.5

1.6

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

111

2.07

2.72

1.3

1.9

1.24

1.34

umol/l

0.60

(3051611) Lipemic interference index of Serum or Plasma

149

1139

1.31

2.65

3.5

3.3

15.40

13.40

index

0.92

617

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

426

3647

1.17

2.65

1.5

1.4

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

188

1482

1.27

2.65

1.1

119.27

117.06

0.40

177

1330

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

562

1.44

2.61

1.3

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

562

1.44

2.61

1.3

1.5

—

(3017509) Phencyclidine [Presence] in Urine

2.25

2.60

2.6

1.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1053

9585

1.11

2.57

1.4

—

(3011412) CD3 cells [#/volume] in Blood

139

1061

1.31

2.52

2.6

2.3

1263.87

1171.25

e6/l

0.73

124

931

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

3.23

2.51

1.1

1.2

—

(4268621) Lupus anticoagulant assay

149

1150

1.30

2.50

2.3

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

4.38

2.47

1.0

1.1

1.50

1.13

mg/l

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

368

3134

1.18

2.47

1.2

1.3

—

(3016330) Potassium [Moles/time] in 24 hour Urine

137

1.90

2.44

1.5

1.2

—

89.82

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.24

2.43

1.1

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

3.34

2.39

1.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

3.34

2.39

1.2

1.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

116

874

1.33

2.33

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

140

1.86

2.31

1.1

—

(3028433) Virus identified in Specimen by Culture

356

1.52

2.28

1.3

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

2.12

2.28

1.0

0.01

0.62

u/ml

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

101

749

1.35

2.26

1.5

7.46

6.90

u/l

0.16

604

(44806071) Cardiolipin IgM antibody measurement

141

1.85

2.26

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

135

1.85

2.21

1.9

2.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

591

1.39

2.20

1.1

1.2

1.08

1.06

ratio

0.36

470

(3020650) Glucose [Presence] in Urine

361

1.50

2.16

1.8

1.7

0.06

0.03

estimate

0.15

361

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

199

1626

1.23

2.12

5.7

6.5

12.12

12.11

mg/l

0.01

176

1504

(3028271) Lactate [Moles/volume] in Capillary blood

218

1798

1.22

2.12

2.1

1.8

1.64

1.68

mmol/l

0.29

207

1753

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

190

1546

1.23

2.11

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

707

1.35

2.11

2.4

2.5

0.83

0.67

e9/l

2.03

669

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

130

1012

1.29

2.10

4.7

5.3

123.64

76.11

u/ml

0.35

320

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

242

2019

1.20

2.10

1.2

1.3

306.20

274.18

u/ml

0.58

145

1253

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

144

1138

1.27

2.07

1.2

1.1

97.33

96.61

0.13

138

1066

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

145

1147

1.27

2.07

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

597

5341

1.12

2.05

4.5

5.0

1.66

1.60

0.65

563

5076

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

161

1.74

2.05

1.8

1.5

5.38

244037.14

nmol/l

0.91

134

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.32

2.04

1.2

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

318

1.51

2.02

2.6

3.0

2.41

1.98

ratio

0.62

293

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.11

2.02

1.2

1.1

1.52

1.64

iu/ml

0.11

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

125

1.84

2.02

3.3

2.6

0.57

0.50

u/field

0.14

125

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

2.00

1.0

0.00

4.98

u/ml

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

327

1.50

2.00

1.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

155

1.74

1.99

1.1

1.0

102.16

78.50

ug/l

1.45

115

(3033099) Centromere Ab [Titer] in Serum

271

1.55

1.99

1.2

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

163

1.72

1.97

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

604

1.36

1.97

1.1

1.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

119

1.85

1.96

1.3

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.19

1.94

1.2

—

(3002619) Bacteria identified in Specimen by Culture

282

1.53

1.91

1.3

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

211

1.61

1.90

1.6

1.5

0.49

0.50

e9/l

0.01

211

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

135

1.78

1.90

1.7

1.4

0.25

0.27

nmol/l

0.11

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

217

1813

1.20

1.89

1.4

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

340

1.47

1.88

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

340

1.47

1.88

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

340

1.47

1.88

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

340

1.47

1.88

1.2

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

113

880

1.29

1.86

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

178

1463

1.22

1.84

1.5

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

116

908

1.28

1.84

1.2

143.00

176.67

titre

0.21

153

(37021550) Renin [Units/volume] in Plasma --upright

229

1.57

1.83

1.1

1.3

86.52

78.65

mu/l

0.08

169

(4195642) Thrombophilia screening test

178

1464

1.22

1.83

1.2

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

4.17

1.82

1.0

1.1

—

(3036180) Methadone [Presence] in Urine

4.17

1.82

2.4

2.9

—

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

2.00

1.79

1.3

1.53

1.02

ml/s/173m2

—

(3005033) Fetal Nuchal fold Thickness US

117

1477

0.79

1.79

1.5

1.26

0.01

1049

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

215

1.58

1.78

1.1

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.17

1.77

1.6

1.5

399.77

308.48

umol/24h

0.97

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

145

1784

0.81

1.76

1.4

1.5

—

(3004809) Band form neutrophils/Leukocytes in Blood

238

2021

1.18

1.75

2.8

3.6

1.04

1.56

2.76

211

1809

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

321

1.47

1.75

1.1

1.2

84.83

88.17

0.22

155

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

330

1.46

1.73

1.1

88.67

87.78

0.05

153

(4281824) Cell count and differential, peritoneal fluid

108

1370

0.79

1.73

1.2

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.67

1.72

1.0

1.2

22.39

34.10

umol/24h

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

2.13

1.71

1.0

3.10

3.99

u/ml

—

(3017704) Immunofixation for Urine

637

1.32

1.71

1.4

1.6

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

242

1.53

1.69

1.1

1.2

52.99

61.78

u/ml

0.35

234

(3047352) Trisomy 18 risk [Likelihood] in Fetus

120

1497

0.80

1.68

1.5

—

(3005011) Chlamydia sp Ab [Titer] in Serum

141

1.70

1.67

1.7

1.6

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

391

1.41

1.67

2.6

0.62

mmol/l

0.03

391

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

148

1804

0.82

1.66

1.4

1.5

1.25

1.18

ratio

0.32

1083

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

148

1804

0.82

1.66

1.4

1.5

0.96

0.95

ratio

0.20

1077

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

130

1047

1.24

1.66

1.2

—

(3006567) Chloride [Moles/time] in 24 hour Urine

3.16

1.66

1.0

1.1

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

157

1.66

1.65

2.2

3.0

84.33

41.24

mg/l

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

1.89

1.64

1.0

0.01

0.75

u/ml

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

148

1801

0.82

1.64

1.4

1.5

1.19

1.16

ratio

0.12

1074

(3014148) Varicella zoster virus Ab [Titer] in Serum

162

1338

1.21

1.63

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

275

2380

1.16

1.62

5.1

5.3

1351.00

1813.59

iu/ml

0.17

329

(3035285) Chloride [Moles/volume] in Venous blood

105

1323

0.79

1.61

2.5

2.3

106.29

105.57

mmol/l

0.92

105

1311

(3041354) Potassium [Moles/volume] in Venous blood

105

1323

0.79

1.61

2.5

2.3

4.04

4.07

mmol/l

0.23

105

1311

(3012565) Volume of 24 hour Urine

565

1.33

1.61

2.1

2.2

2135.81

1881.76

1.08

504

(3034891) Synovial lining cells/cells in Synovial fluid

531

1.34

1.60

1.5

1.40

4.14

—

113

(3048879) Bone marrow aspiration report

311

1.45

1.60

1.3

1.8

—

2.00

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

218

1859

1.18

1.56

2.6

141.91

1418.08

u/ml

1.97

109

(3033923) Metanephrine [Moles/time] in 24 hour Urine

223

1.53

1.56

1.1

0.75

0.64

umol/24h

0.81

(3044009) aPTT.lupus sensitive (LA screen)

1.97

1.53

1.5

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

720

1.28

1.52

1.1

—

0.62

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

580

1.31

1.51

2.3

2.4

200.59

202.86

u/l

0.11

572

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

172

1442

1.20

1.51

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.16

1.50

7.9

4.6

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

669

1.29

1.49

1.9

1.5

77.70

82.51

umol/l

0.87

669

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

469

1.35

1.49

1.3

1.1

8.27

15.90

u/ml

0.36

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

384

1.38

1.48

2.4

3.2

4.88

4.92

kpa

0.09

384

(3018133) Calcium [Moles/volume] in Urine

210

1.53

1.48

2.1

1.7

2.63

2.59

mmol/l

0.04

185

(3043238) Trisomy 21 risk [Likelihood] in Fetus

127

1544

0.82

1.44

1.5

1.6

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

3.13

1.44

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

133

1609

0.82

1.43

1.5

1.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

234

2025

1.16

1.42

1.6

1.7

—

(4015189) Microbial culture of sputum

286

1.44

1.42

2.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

537

4892

1.10

1.42

4.6

5.3

0.88

0.87

0.39

502

4638

(3033705) Calcium.ionized [Moles/volume] in Venous blood

105

1298

0.81

1.40

2.5

2.3

1.21

1.20

mmol/l

1.75

105

1286

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.41

1.39

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

297

3361

0.88

1.39

1.5

1.6

986.11

992.10

mu/l

0.04

254

2791

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.20

1.36

1.0

1.1

487.44

265.10

nmol/l

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

2.61

1.36

1.0

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

2.94

1.36

1.2

1.0

1.18

3.79

u/ml

—

(3052592) Norovirus Ag [Presence] in Stool

207

1.50

1.34

1.2

1.3

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

120

1.67

1.33

1.1

12.13

7.30

u/ml

0.47

120

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

164

1931

0.85

1.33

1.5

62.02

61.33

ug/l

0.06

140

1598

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

584

1.29

1.32

1.7

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

584

1.29

1.32

1.7

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

584

1.29

1.32

1.7

1.8

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

249

1.45

1.32

1.0

1.1

5.88

5.03

u/ml

0.06

131

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

385

1.35

1.30

2.4

3.2

11.26

10.24

kpa

1.21

385

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

586

1.28

1.30

1.7

1.8

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

137

1.61

1.29

2.3

2.1

0.45

1.10

mmol/l

2.15

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

945

10064

0.93

1.26

2.0

3.40

3.44

ratio

0.51

727

7775

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

383

3463

1.11

1.21

3.2

1.51

1.59

mg/l

1.23

346

3138

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

332

2979

1.12

1.21

1.4

1.3

277.87

218.76

miu/ml

1.72

134

1314

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

221

1.45

1.20

1.2

63.50

73.15

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

331

1.36

1.20

1.1

1.2

657.14

928.79

titre

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.31

1.18

1.0

2.36

1.60

u/ml

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

222

1.44

1.18

1.1

1.2

90.88

76.21

—

(3004451) EKG impression Narrative

694

1.24

1.17

1.4

1.3

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

1.93

1.16

1.0

0.03

2.57

u/ml

0.69

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

1.16

0.0

1.1

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

2.50

1.15

1.8

1.3

143.60

120.00

nmol/l

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

120

1005

1.20

1.14

1.5

29.08

30.99

0.22

603

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

449

0.71

1.13

1.4

1.6

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

572

1.26

1.12

4.1

4.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

103

1.65

1.12

1.1

1.3

68.71

68.06

ug/l

0.02

103

(3036071) Salmonella sp Ab [Titer] in Serum

318

1.35

1.12

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

397

1.31

1.10

1.1

1.2

—

(3000012) Reticulocyte production index

202

1771

1.14

1.09

1.8

2.1

0.81

0.91

2.18

123

1193

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

559

1.25

1.06

2.2

1.9

1.75

2.72

u/field

0.73

383

(40762814) Titanium [Mass/volume] in Blood

194

1.44

1.06

2.4

3.53

3.81

ug/l

—

(1761868) Lipid panel - Serum or Plasma

3789

38815

0.97

1.06

3.3

3.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

129

1.55

1.05

1.2

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

101

1208

0.83

1.04

1.4

1.5

55.27

60.21

ug/l

0.74

101

1208

(40758292) HTLV I+II Ab panel - Serum

204

0.59

1.04

1.3

1.4

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

116

1369

0.85

1.03

1.3

7.43

7.40

mmol/l

0.04

1199

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

122

1036

1.18

1.02

1.3

1.5

2.60

3.98

ug/l

1.69

104

876

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

170

1484

1.15

1.00

1.5

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

763

1.21

1.00

1.3

1.2

73.22

89.35

u/l

1.21

640

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.00

1.00

3.9

3.8

—

(3009677) Dengue virus Ab [Presence] in Serum

2.00

1.00

1.0

1.1

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

131

1.53

0.99

1.1

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

107

1.59

0.99

1.1

1.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.80

0.98

1.2

1.1

—

(3017400) Magnesium [Moles/volume] in Urine

2.17

0.98

2.0

1.0

2.25

2.53

mmol/l

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

0.00

0.97

0.0

4.7

—

4.99

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

1.69

0.95

1.8

1.3

21.83

mmol/l

—

(3017569) Oxygen content in Arterial blood

678

1.21

0.93

2.2

2.3

16.19

15.89

0.39

678

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

125

1.52

0.93

1.1

1.0

0.00

0.44

u/ml

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

444

1.26

0.93

1.2

1.3

9.70

10.67

mm/h

0.33

444

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

260

1.35

0.92

2.8

7.0

66.00

70.98

0.41

200

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

322

1.31

0.90

1.8

2.0

8.30

9.27

mg/l

0.65

271

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

565

0.78

0.90

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

102

1.57

0.90

1.0

2.18

0.55

u/ml

—

(21494434) Karyotype in Bone marrow

118

1013

1.17

0.90

1.2

—

(40768806) Pleura Pathology biopsy report

112

1306

0.86

0.89

1.5

1.6

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

701

7435

0.94

0.89

1.8

1.7

3.38

3.47

mmol/l

1.54

490

5150

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

1.91

0.88

1.5

1.2

1.54

2.02

mg/l

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

152

1.45

0.87

2.1

1.7

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

111

1.53

0.87

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.86

0.87

1.0

9.14

8.38

mmol/l

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

288

0.69

0.86

1.8

1.5

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

530

1.23

0.86

1.2

1.1

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

195

1.39

0.85

1.7

2.1

1.19

1.20

mmol/l

0.31

189

(3044007) Cell count panel - Peritoneal fluid

390

0.74

0.84

2.8

1.8

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

743

1.19

0.83

1.3

1.2

18.96

25.85

u/l

0.98

610

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

1.69

0.82

1.0

1.1

—

3.90

—

(3024316) Viscosity of Plasma

1.72

0.79

2.3

1.6

1.56

1.60

mpas

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

156

1.41

0.78

1.0

1.1

1.01

6.07

u/ml

0.67

102

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.52

0.78

1.6

2.4

0.52

0.65

ug/l

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

234

1.33

0.77

1.6

53.84

102.50

au/ml

—

(3000285) Sodium [Moles/volume] in Blood

235

1.32

0.75

1.1

1.2

138.28

138.59

mmol/l

0.12

191

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.64

0.75

1.0

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

678

1.18

0.75

1.8

2.0

8.08

7.92

mmol/l

0.12

678

(46235168) Fasting glucose [Moles/volume] in Blood

116

1.47

0.74

3.9

3.0

8.06

7.17

mmol/l

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

104

902

1.15

0.73

2.0

2.02

1.64

u/field

0.35

486

(40761995) Spermatozoa Progressive [#/volume] in Semen

135

0.59

0.73

3.6

3.1

42.00

43.51

—

135

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

135

0.59

0.73

7.3

6.1

9.25

8.20

—

135

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

101

875

1.16

0.73

1.4

1.5

12.12

13.02

u/l

0.73

838

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

281

1.28

0.72

1.3

1.2

35.24

39.42

0.24

190

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

255

1.29

0.71

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

498

1.21

0.71

2.6

3.5

1.53

1.31

0.39

498

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

892

0.85

0.71

1.3

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.92

0.70

1.0

5.6

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

427

1.22

0.69

2.5

1.8

411.88

59740.40

u/ml

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.53

0.68

2.8

2.4

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.53

0.68

1.1

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.53

0.68

1.0

0.01

0.08

u/ml

—

(3050129) First trimester maternal screen panel - Serum or Plasma

202

2219

0.91

0.68

1.3

1.4

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

144

1.39

0.67

5.2

5.9

41.53

43.21

ug/min

0.04

108

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

180

0.67

1.3

1.5

12.57

10.96

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

452

0.80

0.67

2.4

2.0

437.74

3756.77

e6/l

0.94

301

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

108

948

1.14

0.66

1.8

1.6

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

119

1.43

0.66

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

275

2542

1.08

0.65

1.6

1.5

—

(40768446) Kidney Pathology biopsy report

412

1.21

0.65

1.7

1.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

313

2909

1.08

0.65

1.3

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

103

1.46

0.64

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

1.47

0.64

1.0

0.38

0.13

u/ml

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.72

0.64

1.0

1.3

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.72

0.64

5.4

8.5

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.49

0.63

2.1

2.6

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

246

0.73

0.62

2.9

2.5

4.83

173.74

ug/l

0.81

246

(3038071) Oxygen [Partial pressure] in Mixed venous blood

246

0.73

0.62

3.5

7.6

6.15

5.40

kpa

0.44

246

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.52

0.62

1.4

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

188

0.69

0.62

4.4

6.2

9.13

8.10

mmol/l

0.62

188

(3013166) Neutrophils/Leukocytes in Synovial fluid

306

1.24

0.62

1.3

54.37

54.51

0.01

257

(3014891) Appearance of Pleural fluid

147

1.36

0.61

1.1

1.5

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.1

—

10.39

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

236

1.27

0.59

2.1

2.4

7.86

7.71

mmol/l

0.06

148

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

148

1.35

0.59

1.0

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

216

1989

1.09

0.58

1.5

1.6

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

210

1.29

0.58

1.1

22.35

37.63

iu/ml

0.80

210

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.71

0.57

1.0

—

(4035726) Immunohistochemistry procedure

996

10322

0.96

0.57

1.4

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

194

0.72

0.54

3.8

7.0

10.98

10.41

0.36

194

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

413

1.19

0.53

1.1

98.16

93.38

0.64

317

(3020876) Protein [Mass/time] in 24 hour Urine

165

1510

1.09

0.53

2.3

2.4

0.98

1.18

g/24h

0.56

876

(21494814) CD8 cells/Lymphocytes in Specimen

460

1.17

0.53

2.3

2.0

29.54

31.23

0.34

460

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

1.43

0.52

1.0

0.06

0.33

u/ml

—

(44806420) Estimation of glomerular filtration rate

127

1149

1.11

0.52

2.6

2.5

—

(3026250) Tacrolimus [Mass/volume] in Blood

462

1.17

0.51

48.5

38.6

6.69

7.24

ug/l

1.58

416

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

1.46

0.50

1.0

1.1

0.60

1.25

mom

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

106

1177

0.90

0.49

1.3

476.19

373.21

u/l

0.61

100

1114

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

316

1.20

0.49

1.1

1.2

9.20

12.63

pmol/l

0.81

120

(3022475) Manganese [Moles/volume] in Blood

1.47

0.47

1.0

1.4

0.16

umol/l

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

1.46

0.46

1.1

1.2

6.88

2.12

u/ml

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

332

0.81

0.46

1.5

10.57

13.65

g/l

0.84

255

(3042951) Complement C1q Ab [Units/volume] in Serum

1.43

0.46

1.0

1.1

—

25.23

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

759

1.12

0.46

1.2

77.86

82.73

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.61

0.45

1.0

4.9

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

412

1.17

0.45

1.5

1.4

32.55

33.12

nmol/l

0.05

367

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

132

1439

0.92

0.44

1.7

1.8

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

498

1.15

0.43

1.2

1.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

353

3355

1.05

0.43

1.8

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

433

1.16

0.43

1.8

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

433

1.16

0.43

1.8

2.0

—

(3035880) pH of Pleural fluid

639

0.88

0.42

1.2

1.3

7.31

7.41

1.82

432

(3042631) Mycobacterium sp identified in Specimen

172

1598

1.08

0.42

2.7

2.8

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.40

0.42

1.9

1.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

660

1.12

0.42

1.6

1.8

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

203

1.23

0.42

1.2

1.5

—

3158.18

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.41

0.0

1.3

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.41

0.0

1.2

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.41

0.0

2.4

—

(3019174) dRVVT (LA screen)

1.39

0.40

1.5

1.2

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

213

1.22

0.40

2.1

3.3

114.36

135.49

ng/l

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

568

1.13

0.40

1.2

1.3

5.68

5.85

mmol/l

0.79

535

(3041918) Cholesterol [Moles/volume] in Pleural fluid

241

1.20

0.40

1.2

2.11

1.58

mmol/l

0.59

152

(3009015) Lactate [Moles/volume] in Synovial fluid

149

0.74

0.40

1.1

1.2

5.50

6.52

mmol/l

—

(3004775) Volume in Urine collected for unspecified duration

835

0.90

0.39

2.4

2.3

593.69

651.02

0.63

556

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

637

6155

1.04

0.39

2.6

3.9

48.06

70.67

u/ml

1.26

602

5935

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

101

922

1.10

0.38

1.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.35

0.37

2.6

5.6

—

(3034426) Prothrombin time (PT)

345

1.16

0.37

1.1

1.2

27.95

28.36

0.20

345

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

862

0.90

0.37

1.3

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

253

1.19

0.36

1.1

1.3

—

(3034988) Calcium [Moles/volume] in Capillary blood

198

1.21

0.36

1.6

2.2

1.17

1.19

mmol/l

0.91

190

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

330

0.85

0.34

1.4

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

181

1.22

0.34

1.3

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

181

1.22

0.34

1.3

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

181

1.22

0.34

1.3

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

415

0.87

0.34

2.4

1.6

1.28

1538.59

pmol/l

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

873

1.09

0.33

1.8

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.30

0.33

1.2

1.4

—

(40758358) Immune stain study

1.30

0.33

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.70

0.33

1.8

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

101

933

1.08

0.32

1.6

1.5

—

(3003434) Protein [Mass/volume] in Pleural fluid

163

1730

0.94

0.31

1.4

1.5

32.78

32.29

g/l

0.20

150

1556

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.32

0.30

1.3

1.4

—

(40768441) Liver Pathology biopsy report

860

0.92

0.30

1.5

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

438

1.12

0.30

1.8

2.0

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

120

1.25

0.30

1.0

1.3

172.13

96.58

ug/l

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

102

1.27

0.30

1.1

0.04

0.03

u/ml

0.43

102

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.25

0.29

2.0

1.5

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

401

1.12

0.29

1.6

1.8

1.80

2.63

u/ml

—

108

(3024263) Appearance of Synovial fluid

544

1.10

0.29

1.6

1.7

—

(3045142) Bone marrow Pathology biopsy report

139

1307

1.06

0.29

1.1

1.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

867

0.92

0.28

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.25

0.27

5.3

3.5

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

140

1.21

0.27

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

150

0.80

0.27

1.2

1.3

—

(3024471) HLA-A [Type]

300

0.87

0.26

1.0

—

(3026470) Cobalt [Mass/volume] in Blood

711

1.08

0.26

2.3

2.2

3.33

3.74

ug/l

0.24

660

(3036670) Protein [Mass/volume] in Synovial fluid

376

1.12

0.26

1.2

35.97

40.13

g/l

0.45

186

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

913

0.93

0.25

1.3

15.55

14.48

u/l

0.16

831

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.25

0.24

1.1

88.00

94.00

titre

0.11

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

169

0.83

0.23

1.8

1.6

—

(3045788) Cell count panel - Pleural fluid

129

1223

1.06

0.23

1.4

1.5

—

(40768795) Lymph node Pathology biopsy report

124

1176

1.05

0.22

1.2

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.45

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.1

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.21

0.0

1.0

—

(3009992) Blasts/cells in Bone marrow

0.00

0.21

0.0

2.0

—

8.70

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.21

0.0

1.1

—

170.50

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.21

0.0

7.3

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

102

0.78

0.21

4.6

1.9

—

(3025577) Chromium [Mass/volume] in Blood

692

1.07

0.20

2.2

2.11

2.51

ug/l

0.62

577

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

427

4379

0.97

0.20

2.9

3.5

769.77

1873.83

u/ml

0.82

359

3778

(3003771) Antithrombin Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

0.20

0.0

1.1

—

86.56

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

106

1118

0.95

0.20

1.2

1.3

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.15

0.19

1.3

1.2

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

228

0.88

0.19

1.1

1.8

2.70

2.41

ug/l

—

127

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.19

0.18

1.0

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

319

1.10

0.18

2.8

3.6

7.54

8.29

mg/l

0.30

262

(3042733) HLA Ab [Presence] in Serum

319

1.10

0.18

5.4

4.8

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.21

0.17

1.2

1.7

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.13

0.17

1.0

1.1

—

(4133840) Spirometry

268

0.90

0.17

1.3

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

504

1.07

0.17

4.2

5.3

52.00

670.60

u/ml

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

417

1.08

0.16

1.6

1.4

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.18

0.16

1.0

1.1

—

(3001556) Androgen free Index in Serum or Plasma

1.16

0.16

2.4

1.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.14

0.16

1.1

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

140

1.14

0.15

2.1

1.9

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

683

1.05

0.14

6.9

13.99

119.96

ug/l

1.40

440

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

294

1.09

0.14

1.9

1.6

8.73

9.14

ug/l

0.24

294

(3032868) Hemoglobin electrophoresis panel in Blood

0.81

0.14

1.1

1.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

257

2635

0.97

0.14

2.6

3.5

396.53

728.92

u/ml

0.71

238

2391

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

0.82

0.13

1.3

1.8

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

247

1.09

0.13

1.4

1.3

1.18

1.17

mmol/l

0.39

247

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

250

2560

0.98

0.13

1.3

1.5

159.34

182.82

pmol/l

0.12

242

2487

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

180

0.89

0.13

1.4

1.2

30.40

221.96

u/l

—

127

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1261

12721

0.99

0.12

3.5

4.3

24.69

26.50

ug/l

0.05

1021

10444

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

172

1.10

0.11

11.5

11.7

6.84

5.32

mmol/l

0.53

172

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

533

1.05

0.11

2.3

2.1

122.50

147.99

ug/min

0.10

135

(3009871) Measles virus Ab [Titer] in Serum

406

1.06

0.11

1.5

1.7

4096.00

2922.35

titre

—

(3024932) HLA-DR beta [Type]

291

0.93

0.11

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

115

0.87

0.10

1.1

1.2

5.77

6.04

mmol/l

—

115

(40768800) Prostate Pathology biopsy report

209

2136

0.98

0.10

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

115

1185

0.97

0.10

1.3

1.4

6.07

6.35

mmol/l

0.40

107

1095

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

1.14

0.10

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

261

1.07

0.10

1.1

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

673

1.04

0.10

1.6

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

703

1.04

0.09

1.6

1.5

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.06

0.09

1.0

2.1

—

(4211845) Urine protein measurement

574

0.96

0.09

3.6

3.4

—

(3047189) Immunofixation for 24 hour Urine

557

1.04

0.08

1.6

1.7

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.03

0.08

1.3

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.82

0.08

1.4

1.1

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

0.79

0.08

1.2

1.1

—

26.37

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

0.79

0.08

1.2

1.1

—

24.08

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.09

0.08

1.0

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.86

0.07

3.7

3.0

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.81

0.07

3.7

—

0.00

estimate

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

176

1.08

0.07

1.4

1.3

—

(3010375) cycloSPORINE [Mass/volume] in Blood

459

0.96

0.07

38.1

27.8

118.46

109.63

ug/l

0.31

369

(40757373) Influenza virus identified in Isolate

194

0.93

0.07

1.8

1.6

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.83

0.07

1.0

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

0.89

0.06

1.9

1.6

—

(40765089) Chromosome analysis panel - Blood by G-banded

224

0.94

0.06

1.0

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

132

1346

0.98

0.06

1.4

1.5

74206.67

61937.37

e6/l

0.13

740

(3000330) Specific gravity of Urine by Test strip

586

5905

0.99

0.06

3.6

3.5

1.02

ratio

1.53

521

5327

(40768793) Breast Pathology biopsy report

290

2868

1.01

0.06

1.3

—

(3000034) Microalbumin [Mass/volume] in Urine

971

0.98

0.06

2.8

3.0

14.95

50.91

mg/l

2.77

710

(3006462) Nitrate [Presence] in Urine

524

1.03

0.05

3.7

3.5

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

202

0.94

0.05

1.2

1.14

1.58

mmol/l

0.21

137

(3002331) Protein [Mass/volume] in Peritoneal fluid

287

1.05

0.05

1.8

1.4

28.04

27.04

g/l

0.12

221

(3050794) Legionella sp Ab [Presence] in Serum

109

0.92

0.04

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

210

0.95

0.03

2.6

2.9

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

129

0.93

0.03

1.5

1.7

—

(40765096) Chromosome analysis panel by Banding

349

1.03

0.03

1.2

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

361

0.97

0.03

1.3

60.60

348.08

ug/l

1.59

192

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

110

1115

0.99

0.03

2.2

2.4

27.82

27.21

iu/ml

0.03

128

(3051387) C reactive protein [Mass/volume] in Capillary blood

232

2302

1.01

0.03

5.6

3.5

24.38

28.05

mg/l

0.96

165

1595

(3043410) Blood group antigens tested for on Red Blood Cells

310

0.97

0.03

1.3

1.8

—

(4212803) Bone marrow aspirate examination

102

1.08

0.03

1.1

1.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

142

1.06

0.02

1.4

1.6

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

758

0.99

0.01

1.6

1.5

—

(3023199) Leukocytes [#/volume] in Pleural fluid

153

1521

1.01

0.01

1.4

1.5

3764.12

3199.83

e6/l

0.18

113

1054

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

367

0.98

0.01

1.6

1.8

—

(3034092) Cytoplasmic Ig cells/cells in Blood

136

0.96

0.00

7.5

9.9

0.44

0.21

0.69

136

(3022493) Free Hemoglobin [Mass/volume] in Plasma

504

1.01

0.00

1.1

4.2

91.84

950.07

mg/l

0.76

353

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

105

0.95

0.00

1.0

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

385

0.99

0.00

2.3

1.8

36801.83

17354.05

e6/l

0.40

198

(3016750) Collection duration of Urine

595

0.99

0.00

2.3

2.2

487.39

499.34

min

0.37

441

(3013727) Leukocytes other/Leukocytes in Blood

358

1.01

0.00

3.1

3.8

56.18

52.89

0.41

343

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

368

1.01

0.00

1.2

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

231

1.00

0.00

1.3

1.9

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.98

-0.00

1.3

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

620

1.00

-0.00

2.7

2.6

41.89

38.94

0.73

350

(3019529) Immunofixation for Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.4

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

190

1.00

-0.00

1.6

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

-0.00

0.0

1.2

—

36.93

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.89

-0.00

1.0

—

(3001729) Color of Synovial fluid

0.98

-0.00

1.1

1.5

—

(36304079) Mucus [Presence] in Urine sediment

0.00

-0.00

0.0

1.2

—

(3025504) Homovanillate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.2

—

(3010937) Rubella virus Ab [Presence] in Serum

0.94

-0.00

1.2

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

0.87

-0.00

1.5

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.91

-0.00

1.0

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

-0.00

0.0

1.0

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_XTRAPYROTH and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_XTRAPYROTH	1.297 [1.18, 1.42]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.201

During the follow-up period (1.1.1998 — 31.12.2019), 5348 out of 24658 females with G6_XTRAPYROTH died.

Males

Parameter	HR [95% CI]	p-value
G6_XTRAPYROTH	1.541 [1.4, 1.7]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.023

During the follow-up period (1.1.1998 — 31.12.2019), 5694 out of 19166 males with G6_XTRAPYROTH died.

Mortality risk

Mortality risk for people of age

years, who have G6_XTRAPYROTH.

N-year risk	Females	Males
1	0.113%	0.318%
5	0.748%	1.726%
10	1.92%	4.587%
15	3.477%	8.658%
20	6.49%	14.437%

Relationships between endpoints

↥

Index endpoint: G6_XTRAPYROTH – Other extrapyramidal and movement disorders in other diseases

GWS hits: 9

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other extrapyramidal and movement disorders in other diseases

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints